{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:20:13Z","timestamp":1794781213957,"version":"4.9.1"},"reference-count":955,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.healun.2022.10.015","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:57:22Z","timestamp":1671537442000},"page":"e1-e141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":680,"title":["The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients"],"prefix":"10.1016","volume":"42","author":[{"given":"Angela","family":"Velleca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Shullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumud","family":"Dhital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Azeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Farrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garc\u00eda-Guereta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Jamero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Khush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CJ","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Shullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilibeth","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mirabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Urschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Chih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoong Sern","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Velleca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Bellumkonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Dobbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Harkess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Lyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Peled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.10.015_bib0001","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2013.07.032","article-title":"Frailty and risk for heart failure in older adults: the health, aging, and body composition study","volume":"166","author":"Khan","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0002","doi-asserted-by":"crossref","first-page":"e13158","DOI":"10.1111\/ctr.13158","article-title":"The prognostic significance of frailty compared to peak oxygen consumption and B-type natriuretic peptide in patients with advanced heart failure","volume":"32","author":"Moayedi","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0000000000000991","article-title":"The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation","volume":"100","author":"Jha","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2014.02.008","article-title":"Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement","volume":"20","author":"Chung","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2020.11.007","article-title":"The impact of frailty on mortality after heart transplantation","volume":"40","author":"Macdonald","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0884533612457948","article-title":"Nutrition assessment in advanced heart failure patients evaluated for ventricular assist devices or cardiac transplantation","volume":"28","author":"Aggarwal","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.healun.2022.10.015_bib0007","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/SLA.0b013e3181b5db3c","article-title":"The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?","volume":"251","author":"Russo","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0008","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.rec.2017.01.005","article-title":"Prognostic value of the nutritional risk index in heart transplant recipients","volume":"70","author":"Barge-Caballero","year":"2017","journal-title":"Revis Espa\u00f1ola Cardio (English Edition)"},{"key":"10.1016\/j.healun.2022.10.015_bib0009","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10741-016-9540-0","article-title":"Review of nutritional screening and assessment tools and clinical outcomes in heart failure","volume":"21","author":"Lin","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s40140-017-0245-2","article-title":"Prehabilitation and nutritional support to improve perioperative outcomes","volume":"7","author":"West","year":"2017","journal-title":"Curr Anesthesiol Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11914-011-0083-y","article-title":"Osteoporosis after transplantation","volume":"10","author":"Kulak","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0148607114566854","article-title":"Malnutrition and cachexia in heart failure","volume":"40","author":"Rahman","year":"2016","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.healun.2022.10.015_bib0013","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurjhf\/hfr017","article-title":"Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation","volume":"13","author":"Piepoli","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0014","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/SLA.0000000000002293","article-title":"Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial","volume":"267","author":"Barberan-Garcia","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jss.2018.11.042","article-title":"Preoperative exercise rehabilitation in cardiac and vascular interventions","volume":"237","author":"Drudi","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0017","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1037\/hea0000033","article-title":"Physical activity and depression predict event-free survival in heart transplant candidates","volume":"33","author":"Spaderna","year":"2014","journal-title":"Health Psychol"},{"key":"10.1016\/j.healun.2022.10.015_bib0018","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.transproceed.2013.06.009","article-title":"Efficacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients","volume":"45","author":"Karapolat","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.healun.2018.03.005","article-title":"The 2018 ISHLT\/APM\/AST\/ICCAC\/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support","volume":"37","author":"Dew","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.chest.2019.07.028","article-title":"Impact of the new pulmonary hypertension definition on heart transplant outcomes","volume":"157","author":"Crawford","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.015_bib0021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0884533614535269","article-title":"Short-form nutrition assessment in patients with advanced heart failure evaluated for ventricular assist device placement or cardiac transplantation","volume":"29","author":"Yost","year":"2014","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.healun.2022.10.015_bib0022","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008","article-title":"Prognostic value of the pre-transplant diastolic pulmonary artery pressure\u2013to\u2013pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension","volume":"33","author":"Tedford","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0023","doi-asserted-by":"crossref","first-page":"888","DOI":"10.12688\/f1000research.18811.1","article-title":"The 6th world symposium on pulmonary hypertension: what's old is new","volume":"8","author":"Condon","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.healun.2022.10.015_bib0024","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jtcvs.2015.07.012","article-title":"Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival","volume":"150","author":"Tsukashita","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijcard.2014.08.072","article-title":"Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis","volume":"176","author":"Vakil","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0027","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.21037\/jtd.2017.07.24","article-title":"Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation","volume":"9","author":"Koulova","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ejcts\/ezx088","article-title":"Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis","volume":"52","author":"den Uil","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0030","first-page":"110","article-title":"Temporary mechanical circulatory support in cardiac critical care: a state of the art review and algorithm for device selection","volume":"33","author":"Nagpal","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0031","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/CIR.0b013e3182769a54","article-title":"Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association","volume":"126","author":"Peura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0032","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS expert consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0033","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","volume":"65","author":"Rihal","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0034","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rec.2016.12.036","article-title":"Heart transplant and mechanical circulatory support in patients with advanced heart failure","volume":"70","author":"S\u00e1nchez-Enrique","year":"2017","journal-title":"Rev Espa\u00f1ola Cardiol (English Edition)"},{"key":"10.1016\/j.healun.2022.10.015_bib0035","doi-asserted-by":"crossref","first-page":"e13105","DOI":"10.1111\/petr.13105","article-title":"Prelisting predictions of early postoperative survival in infant heart transplantation using classification and regression tree analysis","volume":"22","author":"Chen","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"13","key":"10.1016\/j.healun.2022.10.015_bib0036","first-page":"224","article-title":"Risk factors for early and late mortality in pediatric heart transplantation","author":"Peng","year":"2019","journal-title":"Pediatr Heart Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0037","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1600-6143.2011.03932.x","article-title":"A risk-prediction model for in-hospital mortality after heart transplantation in US children: risk prediction in pediatric heart transplant","volume":"12","author":"Almond","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0038","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.healun.2017.03.002","article-title":"Pediatric Heart Donor Assessment Tool (PH-DAT): a novel donor risk scoring system to predict 1-year mortality in pediatric heart transplantation","volume":"37","author":"Zafar","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0039","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.healun.2013.11.009","article-title":"Abnormal nutrition affects waitlist mortality in infants awaiting heart transplant","volume":"33","author":"Godown","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPG.0000000000000501","article-title":"ESPGHAN position paper on management of percutaneous endoscopic gastrostomy in children and adolescents","volume":"60","author":"Heuschkel","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.healun.2022.10.015_bib0041","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0042","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.86.3.368","article-title":"Enteral nutrition in infants with congenital heart disease and growth failure","volume":"86","author":"Schwarz","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2022.10.015_bib0043","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/2150135116644641","article-title":"Comparison of feeding strategies for infants with hypoplastic left heart syndrome: a randomized controlled trial","volume":"7","author":"Spillane","year":"2016","journal-title":"World J Pediatr Congenital Heart Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0884533617712502","article-title":"Optimizing nutrition in pediatric heart failure: the crisis is over and now it's time to feed","volume":"33","author":"Lewis","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.healun.2022.10.015_bib0045","unstructured":"WHO Child Growth Standards. Available at: https:\/\/wwwwhoint\/childgrowth\/standards\/en\/. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0046","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.athoracsur.2014.04.087","article-title":"Creation of a quantitative score to predict the need for mechanical support in children awaiting heart transplant","volume":"98","author":"Davies","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0047","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2019.01.038","article-title":"Third annual pediatric interagency registry for mechanical circulatory support (pedimacs) report: preimplant characteristics and outcomes","volume":"107","author":"Morales","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0048","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report \u20132019; Focus theme: Donor and recipient size match","volume":"38","author":"Rossano","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0049","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.jacc.2017.08.072","article-title":"Temporary circulatory support in U.S. children awaiting heart transplantation","volume":"70","author":"Yarlagadda","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0050","unstructured":"Immunization of Immunocompromised Persons: Canadian Immunization Guide. Available at: https:\/\/wwwcanadaca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-personshtml#a22. 2021;2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0051","unstructured":"World Health Organization: immunization, vaccines, and biologicals. Available at: https:\/\/wwwwhoint\/immunization\/diseases\/en\/. 2021;2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0052","doi-asserted-by":"crossref","unstructured":"Danziger-Isakov L, Kumar D. Practice TAICo, Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 2019;33:1-10.","DOI":"10.1111\/ctr.13563"},{"key":"10.1016\/j.healun.2022.10.015_bib0053","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"Executive summary: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0054","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.healun.2020.01.1345","article-title":"ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation","volume":"39","author":"Kirk","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0056","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.healun.2008.11.911","article-title":"Use of hearts transplanted from donors with severe sepsis and infectious deaths","volume":"28","author":"Kubak","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0057","first-page":"33","article-title":"Donor-derived infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","author":"Wolfe","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0058","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0059","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/ajt.14726","article-title":"Changing demographics of heart donors: the impact of donor drug intoxication on posttransplant survival","volume":"18","author":"Ising","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2015.04.253","article-title":"Chronic alcoholic donors in heart transplantation: a mortality meta-analysis","volume":"191","author":"Jacob","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0061","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1093\/ejcts\/ezu512","article-title":"Long-term outcomes in heart transplantation using donors with a history of past and present cocaine use\u2020","volume":"47","author":"Jayarajan","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0062","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1016\/j.healun.2014.01.708","article-title":"Use of heavy drinking donors in heart transplantation is not associated with worse short- and medium-term mortality","volume":"33","author":"Taghavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0063","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.cardfail.2017.07.346","article-title":"Trends and outcomes of cardiac transplantation from donors dying of drug intoxication","volume":"23","author":"Warraich","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0064","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0003-4975(01)02808-9","article-title":"Improved outcome with organs from carbon monoxide poisoned donors for intrathoracic transplantation","volume":"72","author":"Luckraz","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0065","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.transproceed.2008.03.155","article-title":"Cardiac transplantation from a carbon monoxide intoxicated donor","volume":"40","author":"Martin-Suarez","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0066","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.transproceed.2007.11.061","article-title":"Successful cardiac transplantation from donor with carbon monoxide intoxication: a case report","volume":"40","author":"Sezgin","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0067","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1016\/j.transproceed.2010.07.088","article-title":"Prevalence of donor-transmitted coronary artery disease and its influence on heart transplant outcomes","volume":"42","author":"Estevez-Loureiro","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0068","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1253\/circj.CJ-18-0107","article-title":"Impact of coronary artery calcification in the donor heart on transmitted coronary artery disease in heart transplant recipients","volume":"82","author":"Kimura","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.healun.2022.10.015_bib0069","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/icvts\/ivs432","article-title":"Coronary artery bypass graft surgery during heart transplantation","volume":"16","author":"Pinto","year":"2013","journal-title":"Interactive CardioVascular and Thoracic Surgery"},{"key":"10.1016\/j.healun.2022.10.015_bib0070","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/TP.0000000000001322","article-title":"Donor-transmitted atherosclerosis associated with worsening cardiac allograft vasculopathy after heart transplantation: serial volumetric intravascular ultrasound analysis","volume":"101","author":"Watanabe","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0071","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14503\/THIJ-16-5789","article-title":"Bioprosthetic aortic valve replacement in a donor heart before orthotopic heart transplantation","volume":"44","author":"Patel","year":"2017","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.healun.2022.10.015_bib0072","first-page":"96","article-title":"Bench mitral valve repair of donor hearts before orthotopic heart transplantation","volume":"5","author":"Pawale","year":"2012","journal-title":"Circulation: Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0073","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ccr3.1342","article-title":"Combined mitral valve repair and heart transplantation","volume":"6","author":"Sprengel","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0074","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.jtcvs.2017.10.125","article-title":"Concomitant aortic valve replacement with orthotopic heart transplantation","volume":"155","author":"Sultan","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0075","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.0000025587.40373.75","article-title":"Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va","volume":"106","author":"Zaroff","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0076","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/ajt.14354","article-title":"Report from the American Society of Transplantation Conference on donor heart selection in adult cardiac transplantation in the United States","volume":"17","author":"Kobashigawa","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0077","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1111\/j.1600-6143.2011.03744.x","article-title":"Impact of donor left ventricular hypertrophy on survival after heart transplant","volume":"11","author":"Wever Pinzon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0078","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.healun.2017.02.001","article-title":"Low ejection fraction in donor hearts is not directly associated with increased recipient mortality","volume":"36","author":"Chen","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0079","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jacc.2017.07.728","article-title":"Outcomes after transplantation of donor hearts with improving left ventricular systolic dysfunction","volume":"70","author":"Madan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.athoracsur.2019.09.101","article-title":"Cardiac transplantation using hearts with transient dysfunction: role of takotsubo-like phenotype","volume":"110","author":"Madan","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0081","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.jtcvs.2018.07.115","article-title":"Long-term transplant outcomes of donor hearts with left ventricular dysfunction","volume":"157","author":"Sibona","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0082","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report \u2014 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0083","unstructured":"Predicted heart mass calculator. Available at: https:\/\/insightsunosorg\/phm-calculator\/. 2021;2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0084","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.healun.2018.09.017","article-title":"Predicted heart mass is the optimal metric for size match in heart transplantation","volume":"38","author":"Kransdorf","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0085","first-page":"73","article-title":"Cardiac size and sex-matching in heart transplantation","volume":"2","author":"Reed","year":"2014","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0086","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2018.12.067","article-title":"Outcomes of donation after circulatory death heart transplantation in Australia","volume":"73","author":"Chew","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0087","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.healun.2017.10.021","article-title":"Outcome after heart transplantation from donation after circulatory-determined death donors","volume":"36","author":"Messer","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0088","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/fca-2020-0070","article-title":"Donors after circulatory death heart trial","volume":"17","author":"Shudo","year":"2021","journal-title":"Fut Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0089","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nefro.2015.03.001","article-title":"Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease","volume":"35","author":"Alkhouli","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/j.healun.2022.10.015_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1749-8090-3-44","article-title":"The effect of a large proximal haemodialysis arterio-venous fistula on weaning off cardiopulmonary bypass: case report","volume":"3","author":"Nyawo","year":"2008","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0091","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.jvca.2017.09.018","article-title":"Anesthetic and perioperative considerations for combined heart-kidney transplantation","volume":"32","author":"Mc Loughlin","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0092","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.transproceed.2016.11.040","article-title":"Combined heart and kidney transplantation: a 23-year experience","volume":"49","author":"Awad","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0093","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.athoracsur.2019.02.012","article-title":"Heart-kidney and heart-liver transplantation provide immunoprotection to the cardiac allograft","volume":"108","author":"Chou","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0094","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report\u20142018; focus theme: multiorgan transplantation","volume":"37","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clinre.2018.08.009","article-title":"Combined heart and liver transplantation: state of knowledge and outlooks","volume":"43","author":"Lebray","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.healun.2022.10.015_bib0096","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.athoracsur.2012.09.010","article-title":"Combined heart and liver transplantation: the cleveland clinic experience","volume":"95","author":"Nagpal","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0097","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.athoracsur.2012.10.080","article-title":"Impact of ventricular assist device complications on posttransplant survival: an analysis of the united network of organ sharing database","volume":"95","author":"Healy","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0098","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.healun.2015.07.007","article-title":"Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices\u2014an analysis of the International Society for Heart and Lung Transplantation Transplant Registry","volume":"35","author":"Healy","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0099","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.118.036932","article-title":"Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation mortality: a propensity-matched analysis of the united network of organ sharing database","volume":"140","author":"Truby","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0100","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.healun.2019.04.003","article-title":"Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices","volume":"38","author":"Yin","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0101","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.jvca.2007.11.003","article-title":"Concomitant pulmonary hypertension and vasoplegia syndrome after heart transplant: a challenging picture","volume":"22","author":"Bozzetti","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MAT.0000000000000623","article-title":"Incidence and impact of on-cardiopulmonary bypass vasoplegia during heart transplantation","volume":"64","author":"Truby","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2022.10.015_bib0103","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.107.653576","article-title":"Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle","volume":"117","author":"Haddad","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0104","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1213\/XAA.0000000000000271","article-title":"Prothrombin complex concentrate and methylene blue for treatment of coagulopathy and vasoplegia in a pediatric heart transplant patient","volume":"6","author":"Lee","year":"2016","journal-title":"A Case Reports"},{"key":"10.1016\/j.healun.2022.10.015_bib0106","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Critical Care"},{"key":"10.1016\/j.healun.2022.10.015_bib0107","series-title":"Heart Transplantation","author":"Kirklin","year":"2002"},{"key":"10.1016\/j.healun.2022.10.015_bib0108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccc.2018.08.008","article-title":"Perioperative Management of the Cardiac Transplant Recipient","volume":"35","author":"Rabin","year":"2019","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.healun.2022.10.015_bib0109","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.amjcard.2018.08.035","article-title":"Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation","volume":"122","author":"Raza","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.jvca.2015.12.013","article-title":"Use of oral droxidopa to improve arterial pressure and reduce vasoactive drug requirements during persistent vasoplegic syndrome after cardiac transplantation","volume":"30","author":"Zundel","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0111","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007890-200108270-00013","article-title":"Inhaled nitric oxide for pulmonary hypertension after heart transplantation","volume":"72","author":"Ardehali","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0112","first-page":"443","article-title":"Low doses of inhaled nitric oxide in heart transplant recipients","volume":"15","author":"Auler Junior","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0113","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery","volume":"127","author":"De Wet","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0114","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients","volume":"138","author":"Khan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0115","first-page":"436","article-title":"Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside","volume":"14","author":"Kieler-Jensen","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0116","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1060028015608865","article-title":"A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery","volume":"50","author":"McGinn","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.healun.2022.10.015_bib0117","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.jvca.2017.12.014","article-title":"Inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI 2) use in cardiothoracic surgical patients: is there sufficient evidence for evidence-based recommendations?","volume":"32","author":"Rao","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0118","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcrc.2013.03.006","article-title":"Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients","volume":"28","author":"Torbic","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.healun.2022.10.015_bib0119","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.hrthm.2010.06.026","article-title":"Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS\/OPTN cardiac transplant database","volume":"7","author":"Cantillon","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.healun.2022.10.015_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pace.13021","article-title":"A Single Center Study of 1,179 Heart Transplant Patients-Factors Affecting Pacemaker Implantation: PACEMAKER IMPLANTATION AFTER HEART TRANSPLANTATION","volume":"40","author":"Wellmann","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0121","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0122","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jacc.2018.10.044","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0123","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2005.07.017","article-title":"Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter","volume":"25","author":"Ahmari","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0124","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/DDDT.S96126","article-title":"Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation","author":"Doesch","year":"2016","journal-title":"Drug Design, Dev Therapy"},{"key":"10.1016\/j.healun.2022.10.015_bib0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jce.12078","article-title":"Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes: catheter ablation of atrial arrhythmias","volume":"24","author":"Nof","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0126","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.117.028087","article-title":"Prospective study of adenosine on atrioventricular nodal conduction in pediatric and young adult patients after heart transplantation","volume":"135","author":"Flyer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0127","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/157340311797484286","article-title":"Postoperative care of the transplanted patient","volume":"7","author":"Schumacher","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardfail.2017.12.012","article-title":"Consequences of retained defibrillator and pacemaker leads after heart transplantation\u2014an underrecognized problem","volume":"24","author":"Holzhauser","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0129","article-title":"Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2022.10.015_bib0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/pace.12274","article-title":"Frequency and sequelae of retained implanted cardiac device material post heart transplantation: retained cardiac device material posttransplantation","volume":"37","author":"Martin","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0131","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1210\/jc.2015-1959","article-title":"Perioperative tight glucose control reduces postoperative adverse events in nondiabetic cardiac surgery patients","volume":"100","author":"Bl\u00e1ha","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.healun.2022.10.015_bib0132","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","article-title":"Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients","volume":"40","author":"Jacobi","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0133","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.healun.2022.10.015_bib0134","doi-asserted-by":"crossref","unstructured":"Abbo LM, Grossi PA. Practice tAICo, Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-19.","DOI":"10.1111\/ctr.13589"},{"key":"10.1016\/j.healun.2022.10.015_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0136","doi-asserted-by":"crossref","first-page":"e6903","DOI":"10.1097\/MD.0000000000006903","article-title":"Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis","volume":"96","author":"de Jonge","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.healun.2022.10.015_bib0137","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.athoracsur.2006.09.046","article-title":"The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part ii: antibiotic choice","volume":"83","author":"Engelman","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0138","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41390-019-0523-4","article-title":"Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients","volume":"87","author":"Albatati","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0139","doi-asserted-by":"crossref","unstructured":"Allen UD, Preiksaitis JK. Practice tAIDCo, Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-22.","DOI":"10.1111\/ctr.13652"},{"key":"10.1016\/j.healun.2022.10.015_bib0140","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0141","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.healun.2010.01.013","article-title":"Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients","volume":"29","author":"Manlhiot","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0142","doi-asserted-by":"crossref","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients\u2014guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-23.","DOI":"10.1111\/ctr.13512"},{"key":"10.1016\/j.healun.2022.10.015_bib0143","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.healun.2007.09.027","article-title":"Relationship of immunosuppression to Epstein\u2013Barr viral load and lymphoproliferative disease in pediatric heart transplant Patients","volume":"27","author":"Schubert","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0144","doi-asserted-by":"crossref","unstructured":"Lee DH, Zuckerman RA. Practice obotAIDCo, Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-10.","DOI":"10.1111\/ctr.13526"},{"key":"10.1016\/j.healun.2022.10.015_bib0145","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/TP.0000000000002020","article-title":"Endemic fungal infection recommendations for solid-organ transplant recipients and donors","volume":"102","author":"Abdala","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0146","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation","volume":"33","author":"Blair Janis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/TP.0000000000002027","article-title":"Recommendations for management of endemic diseases and travel medicine in solid-organ transplant recipients and donors: Latin America","volume":"102","author":"Clemente","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0148","doi-asserted-by":"crossref","unstructured":"Fishman JA, Gans H. Practice tAIDCo, Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-12","DOI":"10.1111\/ctr.13587"},{"key":"10.1016\/j.healun.2022.10.015_bib0149","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01710735","article-title":"Pneumocystis carinii pneumonia in heart transplant recipients","volume":"21","author":"Grossi","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.healun.2022.10.015_bib0150","first-page":"525","article-title":"Coccidioidomycosis and heart transplantation","volume":"12","author":"Hall","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0151","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/ciy682","article-title":"A multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients","volume":"68","author":"Hosseini-Moghaddam","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0152","doi-asserted-by":"crossref","unstructured":"Husain S, Camargo JF. Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-24.","DOI":"10.1111\/ctr.13544"},{"key":"10.1016\/j.healun.2022.10.015_bib0153","doi-asserted-by":"crossref","first-page":"e12744","DOI":"10.1111\/tid.12744","article-title":"Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area","volume":"19","author":"Lohrmann","year":"2017","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0154","doi-asserted-by":"crossref","unstructured":"Miller R, Assi M. Practice tAIDCo, Endemic fungal infections in solid organ transplant recipients\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-15.","DOI":"10.1111\/ctr.13553"},{"key":"10.1016\/j.healun.2022.10.015_bib0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.TP.0000044358.99414.B8","article-title":"The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis","volume":"75","author":"Mu\u00f1oz","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0156","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2004.00390.x","article-title":"Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis","volume":"4","author":"Munoz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0157","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/TP.0b013e31829e6d7b","article-title":"Targeted antifungal prophylaxis in heart transplant recipients","volume":"96","author":"Mu\u00f1oz","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0158","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1399-3062.1999.010402.x","article-title":"Epidemiology of fungal infections in solid organ transplant patients: Fungal infections in solid organ transplantation","volume":"1","author":"Patterson","year":"1999","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0159","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.tp.0000441088.01723.ee","article-title":"Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection","volume":"97","author":"Tissot","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322733","article-title":"Infectious complications among 620 consecutive heart transplant patients at stanford university medical center","volume":"33","author":"Montoya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0161","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3201\/eid2408.180045","article-title":"Toxoplasmosis in transplant recipients, Europe, 2010\u20132014","volume":"24","author":"Robert-Gangneux","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0162","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.healun.2022.10.015_bib0163","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2011.12.001","article-title":"Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support","volume":"143","author":"Gardner","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0164","doi-asserted-by":"crossref","unstructured":"La Hoz RM, Morris MI. Transplantation tIDCoPotASo, Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients\u2014 guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-20.","DOI":"10.1111\/ctr.13546"},{"key":"10.1016\/j.healun.2022.10.015_bib0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1399-3046.2011.01589.x","article-title":"Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients: pediatric outcomes of Pneumocystis jiroveci pneumonia","volume":"15","author":"Ng","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0166","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jpids\/pix041","article-title":"Invasive fungal disease in pediatric solid organ transplant recipients","volume":"7","author":"Saxena","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.healun.2022.10.015_bib0167","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-3046.2010.01415.x","article-title":"Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes: fungal infections in pediatric heart transplants","volume":"15","author":"Zaoutis","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0168","doi-asserted-by":"crossref","unstructured":"Rychik J, Atz AM, Celermajer DS, et al. Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American Heart Association. Circulation 2019;140:e234-e284.","DOI":"10.1161\/CIR.0000000000000696"},{"key":"10.1016\/j.healun.2022.10.015_bib0169","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.amjcard.2017.02.005","article-title":"Mortality risk stratification in fontan patients who underwent heart transplantation","volume":"119","author":"Berg","year":"2017","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.healun.2022.10.015_bib0170","first-page":"28","article-title":"Heart transplantation for the failed fontan","author":"Gokanapudy","year":"2019","journal-title":"Pediatric heart transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0171","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.healun.2018.07.007","article-title":"Center volume and post-transplant survival among adults with congenital heart disease","volume":"37","author":"Menachem","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0172","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1017\/S1047951120000864","article-title":"Treatment strategies for protein-losing enteropathy in Fontan-palliated patients","volume":"30","author":"Schleiger","year":"2020","journal-title":"Cardiol Young"},{"key":"10.1016\/j.healun.2022.10.015_bib0173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.healun.2018.09.024","article-title":"Fontan-associated protein-losing enteropathy and post\u2012heart transplant outcomes: a multicenter study","volume":"38","author":"Schumacher","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0174","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCINTERVENTIONS.112.972265","article-title":"Acute effects of embolizing systemic-to-pulmonary arterial collaterals on blood flow in patients with superior cavopulmonary connections: a pilot study","volume":"6","author":"Dori","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.healun.2022.10.015_bib0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1053-2498(03)00305-X","article-title":"Management of aortopulmonary collaterals in children following cardiac transplantation for complex congenital heart disease","volume":"23","author":"Krishnan","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0176","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0177","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.healun.2018.01.1291","article-title":"The management of antibodies in heart transplantation: an ISHLT consensus document","volume":"37","author":"Kobashigawa","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0178","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0179","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.healun.2016.03.021","article-title":"Desensitization strategies in adult heart transplantation\u2014Will persistence pay off?","volume":"35","author":"Chih","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0180","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2016.05.001","article-title":"Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant","volume":"35","author":"Ko","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0181","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.healun.2015.10.013","article-title":"Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens","volume":"35","author":"Reinsmoen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0182","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jtcvs.2009.12.034","article-title":"Glutaraldehyde treatment of allograft tissue decreases allosensitization after the Norwood procedure","volume":"139","author":"Laing","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0183","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.healun.2011.06.005","article-title":"Allosensitization and outcomes in pediatric heart transplantation","volume":"30","author":"Mahle","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0184","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.athoracsur.2017.03.008","article-title":"Glutaraldehyde treatment of allografts and aortic outcomes post-norwood: challenging surgical decision","volume":"104","author":"Martin","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0185","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejcts.2004.12.033","article-title":"Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation","volume":"27","author":"Meyer","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0186","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.16420","article-title":"Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients","volume":"21","author":"Patel","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0187","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant."},{"key":"10.1016\/j.healun.2022.10.015_bib0188","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM200103153441102","article-title":"ABO-incompatible heart transplantation in infants","volume":"344","author":"West","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0189","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1191\/0267659104pf708oa","article-title":"ABO-incompatible heart transplantation: a perfusion strategy","volume":"19","author":"Foreman","year":"2004","journal-title":"Perfusion"},{"key":"10.1016\/j.healun.2022.10.015_bib0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.healun.2012.11.022","article-title":"ABO-incompatible heart transplantation in early childhood: an international multicenter study of clinical experiences and limits","volume":"32","author":"Urschel","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0191","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.healun.2020.02.008","article-title":"A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation","volume":"39","author":"Urschel","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0192","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s00134-013-2973-1","article-title":"Neurodevelopmental, educational and behavioral outcome at 8 years after neonatal ECMO: a nationwide multicenter study","volume":"39","author":"Madderom","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0193","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2019.01.1310","article-title":"Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients","volume":"38","author":"Profita","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0194","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.athoracsur.2015.02.047","article-title":"Predictors and outcome of extracorporeal life support after pediatric heart transplantation","volume":"99","author":"Simmonds","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0195","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.healun.2015.03.013","article-title":"ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titers","volume":"34","author":"Irving","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0196","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1600-6143.2011.03913.x","article-title":"Donor-specific isohemagglutinins: measuring the unknown: isohemagglutinins: measuring the unknown","volume":"12","author":"Jeyakanthan","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0197","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5858\/2008-132-1194-RTVIPO","article-title":"Reducing the variation in performance of antibody titrations","volume":"132","author":"AuBuchon","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0198","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/trf.14775","article-title":"Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada: PEDIATRIC ABOiHT TRANSFUSION SUPPORT","volume":"58","author":"Dean","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.healun.2022.10.015_bib0199","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.healun.2017.05.006","article-title":"A novel method for ABO-incompatible heart transplantation","volume":"37","author":"Robertson","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0200","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht310.P4888","article-title":"Management of cardiac surgery patients with Heparin-Induced Thrombocytopenia (HIT-II): experience with preoperative plasmaphereses plus intraoperative heparin","volume":"34","author":"Breuer","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0201","doi-asserted-by":"crossref","first-page":"620","DOI":"10.5500\/wjt.v6.i4.620","article-title":"Organ transplantation and drug eluting stents: perioperative challenges","volume":"6","author":"Dalal","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0202","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2253-14-80","article-title":"Comparison of three point-of-care testing devices to detect hemostatic changes in adult elective cardiac surgery: a prospective observational study","volume":"14","author":"Espinosa","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0203","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.015_bib0204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/0971-9784.185523","article-title":"Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation","volume":"19","author":"Hollis","year":"2016","journal-title":"Ann Cardiac Anaesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0205","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.116.023956","article-title":"Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial","volume":"134","author":"Karkouti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0206","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0207","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.015_bib0208","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.transproceed.2019.07.013","article-title":"Heart transplant and hepato-renal dysfunction: the model of end-stage liver disease excluding international normalized ratio as a predictor of postoperative outcomes","volume":"51","author":"Loforte","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0209","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/MAT.0000000000000866","article-title":"Anticoagulation reversal and risk of thromboembolic events among heart transplant recipients bridged with durable mechanical circulatory support devices","volume":"65","author":"Moretz","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2022.10.015_bib0210","first-page":"146","article-title":"Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device","volume":"3","author":"Nassif","year":"2015","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.healun.2022.10.015_bib0211","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1602664","article-title":"Heparin-induced thrombocytopenia in cardiac surgery patients","volume":"43","author":"Pishko","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.healun.2022.10.015_bib0212","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1160\/TH16-03-0230","article-title":"Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients","volume":"116","author":"Selleng","year":"2016","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.healun.2022.10.015_bib0213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/ject\/201850005","article-title":"STS\/SCA\/AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass","volume":"50","author":"Shore-Lesserson","year":"2018","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.healun.2022.10.015_bib0214","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.athoracsur.2018.10.032","article-title":"Prothrombin complex concentrates for warfarin reversal before heart transplantation","volume":"107","author":"Wanek","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0215","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","article-title":"Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.healun.2022.10.015_bib0216","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2017.10.044","article-title":"Impact of prothrombin complex concentrate on blood use, cost, and outcomes in heart transplantation","volume":"105","author":"Wu","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0217","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery","volume":"53","author":"Pagano","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0218","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.hrtlng.2017.05.006","article-title":"Heart transplant centers with multidisciplinary team show a higher level of chronic illness management \u2013 findings from the International BRIGHT Study","volume":"46","author":"Cajita","year":"2017","journal-title":"Heart Lung"},{"key":"10.1016\/j.healun.2022.10.015_bib0219","first-page":"293","article-title":"Improving recovery time following heart transplantation: the role of the multidisciplinary health care team","volume":"6","author":"Roussel","year":"2013","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.healun.2022.10.015_bib0220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/petr.12181","article-title":"A multicenter study of primary graft failure after infant heart transplantation: impact of extracorporeal membrane oxygenation on outcomes","volume":"18","author":"Kaushal","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0221","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","article-title":"Report from a consensus conference on primary graft dysfunction after cardiac transplantation","volume":"33","author":"Kobashigawa","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0222","series-title":"Extracorporeal life support: the ELSO red book","first-page":"387","article-title":"Weaning pediatric cardiac ECMO","author":"Larson","year":"2017"},{"key":"10.1016\/j.healun.2022.10.015_bib0223","first-page":"285","article-title":"Experience of ECMO in primary graft dysfunction after orthotopic heart transplantation","volume":"105","author":"Lima","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0224","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.healun.2019.07.004","article-title":"Structured review of post-cardiotomy extracorporeal membrane oxygenation: part 2-pediatric patients","volume":"38","author":"Lorusso","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/PCC.0000000000002192","article-title":"Extracorporeal membrane oxygenation support after heart transplantation in children\u2014outcomes of a single center cohort","volume":"21","author":"Nair","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/petr.12382","article-title":"Extracorporeal membrane oxygenation support after pediatric orthotopic heart transplantation","volume":"19","author":"Su","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0227","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0228","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0229","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","article-title":"Gene expression profiling for the identification and classification of antibody-mediated heart rejection","volume":"135","author":"Loupy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0230","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.healun.2012.03.009","article-title":"Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant","volume":"31","author":"Everitt","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0231","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1600-6143.2011.03563.x","article-title":"Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0232","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.healun.2016.06.014","article-title":"A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: incidence, therapies and outcomes","volume":"35","author":"Thrush","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0233","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.healun.2015.10.016","article-title":"Mixed cellular and antibody-mediated rejection in heart transplantation: in-depth pathologic and clinical observations","volume":"35","author":"Kfoury","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0234","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/TP.0b013e31826e19e2","article-title":"Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)","volume":"94","author":"Crespo-Leiro","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0235","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart Molecular Microscope Diagnostic (MMDx) system","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0236","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/TP.0b013e318168d571","article-title":"Limited utility of endomyocardial biopsy in the first year after heart transplantation","volume":"85","author":"Hamour","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0237","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/TP.0000000000000615","article-title":"Surveillance endomyocardial biopsy in the modern era produces low diagnostic yield for cardiac allograft rejection","volume":"99","author":"Shah","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0238","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.healun.2018.12.009","article-title":"International Society of Heart and Lung Transplantation position statement on the role of right heart catheterization in the management of heart transplant recipients","volume":"38","author":"Lim","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0239","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1432-2277.2009.00941.x","article-title":"Acute rejection after paediatric heart transplantation: far less common and less severe","volume":"23","author":"Lammers","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.healun.2016.09.017","article-title":"Impact of age on incidence and prevalence of moderate-to-severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation","volume":"36","author":"Zinn","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0241","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.healun.2011.11.019","article-title":"Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience","volume":"31","author":"Daly","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0242","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/petr.12518","article-title":"Variation in the use of surveillance endomyocardial biopsy among pediatric heart transplant centers over time","volume":"19","author":"Godown","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0243","doi-asserted-by":"crossref","first-page":"e13131","DOI":"10.1111\/petr.13131","article-title":"Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation","volume":"22","author":"Zinn","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0244","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.healun.2017.12.008","article-title":"Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: a systematic review","volume":"37","author":"Fitzsimons","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCHEARTFAILURE.113.000697","article-title":"High-sensitivity cardiac troponin I assay to screen for acute rejection in patients with heart transplant","volume":"7","author":"Patel","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0246","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.healun.2003.08.005","article-title":"Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection","volume":"23","author":"Arnau-Vives","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0247","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.healun.2009.04.019","article-title":"The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients","volume":"28","author":"Kittleson","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0248","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.amjcard.2009.01.008","article-title":"Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation","volume":"103","author":"Garrido","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0249","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healun.2018.09.004","article-title":"Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCHEARTFAILURE.114.001658","article-title":"andomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial","volume":"8","author":"Kobashigawa","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0251","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/eurheartj\/ehv682","article-title":"Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II","volume":"37","author":"Crespo-Leiro","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0252","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005629","article-title":"Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype","volume":"13","author":"Sharon","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.healun.2022.10.015_bib0253","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0254","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.healun.2022.10.015_bib0255","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0256","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.healun.2019.11.015","article-title":"Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation","volume":"39","author":"Richmond","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0257","first-page":"e14124","article-title":"Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation","author":"Feingold","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0258","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.healun.2009.12.015","article-title":"Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes","volume":"29","author":"Kobashigawa","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0259","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.healun.2008.10.001","article-title":"Assessment of the cylex ImmuKnow cell function assay in pediatric heart transplant patients","volume":"28","author":"Rossano","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0260","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/TP.0b013e3182466248","article-title":"Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis","volume":"93","author":"Ling","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0261","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival: de novo HLA antibodies after heart transplantation","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0262","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.healun.2016.10.016","article-title":"Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation","volume":"36","author":"Clerkin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0263","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0264","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.healun.2015.05.001","article-title":"Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation","volume":"34","author":"Irving","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0265","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"Duong Van Huyen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0266","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170842","article-title":"Association of serum MiR-142-3p and MiR-101-3p levels with acute cellular rejection after heart transplantation","volume":"12","author":"Sukma Dewi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2022.10.015_bib0267","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.healun.2017.07.012","article-title":"Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection","volume":"37","author":"Kennel","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0268","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1007\/s00330-014-3246-2","article-title":"Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy","volume":"24","author":"Krieghoff","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0269","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10554-018-1364-7","article-title":"Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation","volume":"34","author":"Narang","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0270","first-page":"113","article-title":"Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation","volume":"16","author":"Simsek","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0271","first-page":"1521","article-title":"Prognostic value of myocardial extracellular volume fraction and T2-mapping in heart transplant patients","volume":"13","author":"Chaikriangkrai","year":"2020","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0272","first-page":"1618","article-title":"Native T1 mapping in the diagnosis of cardiac allograft rejection","volume":"12","author":"Imran","year":"2019","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0273","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.12986","article-title":"Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype","volume":"21","author":"Feingold","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0274","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008963","article-title":"Design of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T 2 quantification with MRI in comparison to myocardial biopsies","volume":"5","author":"Bonnemains","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.healun.2022.10.015_bib0275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.healun.2014.12.020","article-title":"Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection","volume":"34","author":"Butler","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0276","first-page":"1632","article-title":"Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation","volume":"12","author":"Dolan","year":"2019","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0277","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-018-0480-9","article-title":"Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis","volume":"20","author":"Vermes","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.healun.2022.10.015_bib0278","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1017\/S1047951119001112","article-title":"Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantation","volume":"29","author":"Evers","year":"2019","journal-title":"Cardiol Young"},{"key":"10.1016\/j.healun.2022.10.015_bib0279","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2015.05.063","article-title":"Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients","volume":"66","author":"Kindel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0280","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.amjcard.2016.02.009","article-title":"Usefulness of diastolic strain measurements in predicting elevated left ventricular filling pressure and risk of rejection or coronary artery vasculopathy in pediatric heart transplant recipients","volume":"117","author":"Lu","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0281","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.echo.2015.06.005","article-title":"Usefulness of two-dimensional strain parameters to diagnose acute rejection after heart transplantation","volume":"28","author":"Mingo-Santos","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2022.10.015_bib0282","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.healun.2015.03.027","article-title":"Global left ventricular relaxation: a novel tissue Doppler index of acute rejection in pediatric heart transplantation","volume":"34","author":"Hernandez","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0283","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-6143.2007.02040.x","article-title":"Multicenter experience of ABO-incompatible pediatric cardiac transplantation","volume":"8","author":"Roche","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0284","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1432-2277.2005.00181.x","article-title":"Successful ABO-incompatible heart transplantation in two infants","volume":"18","author":"Schmoeckel","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0285","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/CIRCULATIONAHA.109.885756","article-title":"Impact of ABO-Incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis","volume":"121","author":"Almond","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0286","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-6143.2009.02934.x","article-title":"Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible","volume":"10","author":"Dipchand","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0287","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.healun.2011.11.013","article-title":"ABO-incompatible heart transplantation: analysis of the Pediatric Heart Transplant Study (PHTS) database","volume":"31","author":"Henderson","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0288","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.healun.2012.09.011","article-title":"Intentional ABO-incompatible heart transplantation: a case report of 2 adult patients","volume":"31","author":"Tyd\u00e9n","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0289","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial: everolimus versus MMF in heart transplantation","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/TP.0b013e3181aacd22","article-title":"Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in De Novo heart transplant recipients","volume":"88","author":"Lehmkuhl","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/535983","article-title":"Efficacy and safety of low-dose cyclosporine with everolimus and steroids in de novo heart transplant patients: a multicentre, randomized trial","volume":"2011","author":"Zuckermann","year":"2011","journal-title":"J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0292","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0b013e3181cbac2d","article-title":"Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial","volume":"89","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0293","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in De Novo heart transplant recipients: three-year results from the randomized SCHEDULE study: early switch to everolimus after transplant","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0294","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial: early switch to everolimus posttransplant","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0295","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: the randomized MANDELA study","volume":"19","author":"Barten","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0296","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in De Novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0297","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with Mycophenolate Mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0298","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0299","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-term sirolimus for primary immunosuppression in heart transplant recipients","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0300","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency: sirolimus in cardiac transplant recipients","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0301","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/ajt.12833","article-title":"Sirolimus conversion after heart transplant: risk factors for acute rejection and predictors of renal function response: renal function after conversion to sirolimus","volume":"14","author":"Zuckermann","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0302","doi-asserted-by":"crossref","first-page":"e13400","DOI":"10.1111\/ctr.13400","article-title":"Allergies and autoimmune disorders in children after heart transplantation","volume":"32","author":"Avdimiretz","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0303","doi-asserted-by":"crossref","first-page":"e13521","DOI":"10.1111\/ctr.13521","article-title":"Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: a multicenter analysis","volume":"33","author":"West","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0304","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1399-3046.2011.01566.x","article-title":"Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients: CNI minimization leads to improved renal function","volume":"15","author":"Chinnock","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0305","doi-asserted-by":"crossref","first-page":"e13054","DOI":"10.1111\/ctr.13054","article-title":"Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation","volume":"31","author":"Asante-Korang","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0306","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1016\/j.healun.2013.01.775","article-title":"Calcineurin inhibitor-free immunosuppression in pediatric heart transplantation recipients: sirolimus as a primary immunosuppressive agent","volume":"32","author":"Loar","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0307","doi-asserted-by":"crossref","DOI":"10.1055\/s-0034-1394000","article-title":"Initial experience with CNI-free immunosuppression in pediatric heart transplant recipients - anticipating PTLD and chronic renal insufficiency","volume":"62","author":"Schubert","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0308","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/TP.0000000000001945","article-title":"Optimizing the safety profile of everolimus by delayed initiation in de novo heart transplant recipients: results of the prospective randomized study EVERHEART","volume":"102","author":"Potena","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0309","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0310","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","article-title":"De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation\u20148-year results","volume":"34","author":"Guethoff","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0311","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.healun.2012.11.028","article-title":"Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus\/mycophenolate mofetil) after heart transplantation: 5-year results","volume":"32","author":"Kaczmarek","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0312","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/0003088-200847120-00007","article-title":"Population pharmacokinetics of mycophenolic acid: a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients","volume":"47","author":"de Winter","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.healun.2022.10.015_bib0313","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.healun.2022.10.015_bib0314","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trre.2010.06.001","article-title":"Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure","volume":"25","author":"Tett","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.healun.2022.10.015_bib0315","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.healun.2011.08.001","article-title":"Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients","volume":"30","author":"Gijsen","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0316","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1399-0012.2009.01198.x","article-title":"The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation: CYP3A5 and dosing of tacrolimus and everolimus","volume":"25","author":"Kniepeiss","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0317","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/FTD.0000000000000080","article-title":"CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients","volume":"36","author":"Lesche","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.healun.2022.10.015_bib0318","doi-asserted-by":"crossref","first-page":"e13285","DOI":"10.1111\/petr.13285","article-title":"A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation","volume":"22","author":"Min","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0319","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.transproceed.2016.11.029","article-title":"Acute calcineurin inhibitor nephrotoxicity secondary to turmeric intake: a case report","volume":"49","author":"Nayeri","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0321","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate","volume":"31","author":"Arora","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0322","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tri.12783","article-title":"Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial","volume":"29","author":"Gullestad","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0323","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1097\/TP.0000000000001706","article-title":"Effect of calcineurin inhibitor\u2013free, everolimus-based immunosuppressive regimen on albuminuria and glomerular filtration rate after heart transplantation","volume":"101","author":"Nelson","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0324","doi-asserted-by":"crossref","first-page":"E649","DOI":"10.1111\/ctr.12241","article-title":"Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation","volume":"27","author":"Gonz\u00e1lez-V\u00edlchez","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0325","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.healun.2016.09.009","article-title":"Use of sirolimus in pediatric heart transplant patients: a multi-institutional study from the Pediatric Heart Transplant Study Group","volume":"36","author":"Rossano","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0326","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cardfail.2021.02.018","article-title":"PCSK9 inhibitors in heart transplant patients: safety, efficacy, and angiographic correlates","volume":"27","author":"Sammour","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0327","doi-asserted-by":"crossref","first-page":"e13984","DOI":"10.1111\/ctr.13984","article-title":"Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: design of the randomized controlled EVOLVD trial","volume":"34","author":"Broch","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0328","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.healun.2022.10.015_bib0329","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","article-title":"Incidence of malignancies in patients treated with sirolimus following heart transplantation","volume":"73","author":"Asleh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0330","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","article-title":"Characteristics of early and late PTLD development in pediatric solid organ transplant recipients","volume":"95","author":"Schober","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0331","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.healun.2022.10.015_bib0332","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14440","article-title":"Impact of induction therapy on outcomes after heart transplantation","volume":"35","author":"Tzani","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0333","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10741-018-9691-2","article-title":"Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis","volume":"23","author":"Briasoulis","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0334","doi-asserted-by":"crossref","first-page":"e13871","DOI":"10.1111\/ctr.13871","article-title":"Induction immunosuppression strategies and long-term outcomes after heart transplantation","volume":"34","author":"Nozohoor","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MAT.0000000000001119","article-title":"Impact of induction immunosuppression on post-transplant outcomes of patients bridged with contemporary left ventricular assist devices","volume":"66","author":"Truby","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2022.10.015_bib0336","doi-asserted-by":"crossref","first-page":"e13651","DOI":"10.1111\/ctr.13651","article-title":"Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era","volume":"33","author":"Amin","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0337","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0338","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety: rituximab in renal transplantation","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0339","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2019.04.056","article-title":"Accelerated allograft vasculopathy with rituximab after cardiac transplantation","volume":"74","author":"Starling","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0340","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.healun.2017.05.010","article-title":"Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: a multi-institutional study","volume":"37","author":"Castleberry","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0341","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.healun.2010.09.005","article-title":"Infection and malignancy after pediatric heart transplantation: the role of induction therapy","volume":"30","author":"Gajarski","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0342","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/TP.0000000000001285","article-title":"Effect of induction therapy on graft survival in primary pediatric heart transplantation: a propensity score analysis of the UNOS database","volume":"101","author":"Butts","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0343","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13366","article-title":"Comparison of 10-year graft failure rates after induction with basiliximab or anti-thymocyte globulin in pediatric heart transplant recipients\u2014The influence of race","volume":"23","author":"Carlo","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0344","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.002790","article-title":"Comparison of basiliximab and anti-thymocyte globulin as induction therapy in pediatric heart transplantation: a survival analysis","volume":"5","author":"Ansari","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.10.015_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13190","article-title":"Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: an analysis of the International Society for Heart and Lung Transplantation database","volume":"22","author":"Butts","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0346","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.healun.2009.09.001","article-title":"Pre-implantation basiliximab reduces incidence of early acute rejection in pediatric heart transplantation","volume":"28","author":"Grundy","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0347","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/TP.0b013e31823f7eea","article-title":"Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients","volume":"93","author":"Morrow","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0348","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.healun.2012.05.009","article-title":"HLA desensitization in pediatric heart transplant candidates: efficacy of rituximab and IVIg","volume":"31","author":"Schumacher","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0349","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0350","series-title":"Product Information: NULOJIX(R) intravenous injection lyophilized powder, belatacept intravenous injection lyophilized powder","year":"2014"},{"key":"10.1016\/j.healun.2022.10.015_bib0351","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT Study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0352","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0353","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/TP.0000000000000404","article-title":"Belatacept maintenance in a heart transplant recipient","volume":"98","author":"Enderby","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0354","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ajt.15584","article-title":"Belatacept-based immunosuppression: a calcineurin inhibitor-sparing regimen in heart transplant recipients","volume":"20","author":"Launay","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0355","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.healun.2022.10.015_bib0356","first-page":"1","article-title":"Targeting the monocyte\u2013macrophage lineage in solid organ transplantation","volume":"8","author":"TPP van den Bosch","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0357","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/14712598.2017.1283400","article-title":"Use of polyclonal\/monoclonal antibody therapies in transplantation","volume":"17","author":"Yeung","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.healun.2022.10.015_bib0358","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A phase I\/II trial of the interleukin-6 receptor\u2013specific humanized monoclonal (Tocilizumab)\u00a0+\u00a0intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0359","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (Anti-Interleukin-6 Receptor monoclonal) as a Potential Treatment for chronic antibody-mediated rejection and transplant glomerulopathy in hla-Sensitized Renal Allograft Recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0360","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajt.13935","article-title":"A steady-state head-to-head pharmacokinetic comparison of all FK-506 (Tacrolimus) Formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period crossover study","volume":"17","author":"Tremblay","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0361","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2011.02.008","article-title":"Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations","volume":"30","author":"Alloway","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0362","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.transproceed.2019.04.028","article-title":"Conversion from immediate-release tacrolimus to prolonged-release tacrolimus in stable heart transplant patients: a retrospective study","volume":"51","author":"Gonz\u00e1lez-V\u00edlchez","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0363","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/DDDT.S52820","article-title":"Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation","volume":"7","author":"Doesch","year":"2013","journal-title":"Drug Design Dev Ther"},{"key":"10.1016\/j.healun.2022.10.015_bib0364","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e3182725532","article-title":"Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring","volume":"95","author":"Kuypers","year":"2013","journal-title":"Transplant J"},{"key":"10.1016\/j.healun.2022.10.015_bib0365","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12581","article-title":"Switching study of kidney transplant patients with tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study","volume":"29","author":"Langone","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0366","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2054358119867993","article-title":"Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian Single-Center Randomized Controlled Trial","volume":"6","author":"Paterson","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0367","doi-asserted-by":"crossref","unstructured":"Vondrak K, Parisi F, Dhawan A, et al. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus. Clin Transplant 2019;33:1-11.","DOI":"10.1111\/ctr.13698"},{"key":"10.1016\/j.healun.2022.10.015_bib0368","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/tri.13479","article-title":"Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus \u2013 a Phase 2, open-label, single-arm, one-way crossover study","volume":"32","author":"Rubik","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0369","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajhp\/40.4.616","article-title":"Stability of allopurinol and of five antineoplastics in suspension","volume":"40","author":"Dressman","year":"1983","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0370","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bmt.1705320","article-title":"Long-term stability of a patient-convenient 1 mg\/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels","volume":"37","author":"Elefante","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0371","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ajhp\/54.2.178","article-title":"Stability of tacrolimus in an extemporaneously compounded oral liquid","volume":"54","author":"Jacobson","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0372","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2146\/ajhp130597","article-title":"Medication absorption considerations in patients with postpyloric enteral feeding tubes","volume":"71","author":"McIntyre","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0373","doi-asserted-by":"crossref","unstructured":"Al Sagheer T, Enderby CY. Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients. Clin Transplant 2019;33:1-6.","DOI":"10.1111\/ctr.13727"},{"key":"10.1016\/j.healun.2022.10.015_bib0374","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1016\/j.transproceed.2010.09.126","article-title":"Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study","volume":"42","author":"Collin","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0375","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/phar.1492","article-title":"Sublingual administration of tacrolimus: current trends and available evidence","volume":"34","author":"Doligalski","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2022.10.015_bib0376","doi-asserted-by":"crossref","first-page":"586","DOI":"10.6002\/ect.2012.0032","article-title":"Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients","volume":"10","author":"Nasiri-Toosi","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0377","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/phar.1149","article-title":"Sublingual tacrolimus: a pharmacokinetic evaluation pilot study","volume":"33","author":"Tsapepas","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2022.10.015_bib0378","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.healun.2011.10.015","article-title":"Use of sublingual tacrolimus in lung transplant recipients","volume":"31","author":"Watkins","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0379","series-title":"NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2016","year":"2016"},{"key":"10.1016\/j.healun.2022.10.015_bib0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03256598","article-title":"Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis","volume":"1","author":"Reams","year":"2002","journal-title":"Am J Respir Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0381","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2146\/ajhp140322","article-title":"Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients","volume":"72","author":"Pennington","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0382","unstructured":"Product Information: PROGRAF(R) oral capsules, IV injection, tacrolimus oral capsules, IV injection. 2011."},{"key":"10.1016\/j.healun.2022.10.015_bib0383","unstructured":"Product Information: Sandimmune(R) oral gelatin capsules, oral solution, intravenous injection, cyclosporine oral soft gelatin capsules, oral solution, intravenous injection. 2013."},{"key":"10.1016\/j.healun.2022.10.015_bib0384","first-page":"2767","article-title":"Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation","volume":"23","author":"Abu-Elmagd","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0385","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/j.healun.2012.01.669","article-title":"655 short-term outcomes in heart transplant recipients treated with generic tacrolimus","volume":"31","author":"Dhungel","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0386","first-page":"1421","article-title":"Conversion to generic cyclosporine A in stable chronic patients after heart transplantation","volume":"7","author":"Kraeuter","year":"2013","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.healun.2022.10.015_bib0387","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/TP.0b013e31822a79ad","article-title":"A multicenter experience with generic tacrolimus conversion","volume":"92","author":"McDevitt-Potter","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0388","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ctr.12564","article-title":"Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients","volume":"29","author":"S\u00f6derlund","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0389","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/phar.1130","article-title":"evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system","volume":"32","author":"Spence","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2022.10.015_bib0390","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0391","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0392","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/TP.0000000000002594","article-title":"Cells and long-lived plasma cells","volume":"103","author":"Ionescu","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0393","doi-asserted-by":"crossref","unstructured":"Hickey MJ, Valenzuela NM, Reed EF. Alloantibody generation and effector function following sensitization to human leukocyte antigen. Front Immunol 2016;7:1-13.","DOI":"10.3389\/fimmu.2016.00030"},{"key":"10.1016\/j.healun.2022.10.015_bib0394","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOT.0000000000000593","article-title":"Measuring alloantibodies: a matter of quantity and quality","volume":"24","author":"Kiernan","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41581-018-0057-8","article-title":"HLA and kidney disease: from associations to mechanisms","volume":"14","author":"Robson","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.healun.2022.10.015_bib0396","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0397","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0398","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0399","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0400","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jtcvs.2019.01.135","article-title":"Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era","volume":"158","author":"Sanchez","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0401","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.healun.2019.07.001","article-title":"Outcomes in patients undergoing cardiac retransplantation: a propensity matched cohort analysis of the UNOS Registry","volume":"38","author":"Miller","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0402","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1600-6143.2007.01902.x","article-title":"Heart retransplantation","volume":"7","author":"Johnson","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0403","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.healun.2021.03.001","article-title":"Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates","volume":"40","author":"Sriwattanakomen","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0404","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2215\/CJN.12031017","article-title":"Immunoglobulin G\u2013Degrading Enzyme of Streptococcus pyogenes (IdeS), Desensitization, and the Kidney Allocation System: Complementary Approaches to Increase Transplantation in Highly HLA Sensitized Patients","volume":"13","author":"Huang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2022.10.015_bib0405","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0406","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/10428194.2018.1459603","article-title":"Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation","volume":"60","author":"Jain","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.healun.2022.10.015_bib0407","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2022.10.015_bib0408","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production: proteasome inhibition of alloantibody production","volume":"9","author":"Perry","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0409","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/ndt\/gfr465","article-title":"Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection","volume":"27","author":"Waiser","year":"2012","journal-title":"Nephrol Dialysis Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0410","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humimm.2012.07.011","article-title":"Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft","volume":"73","author":"Fishbein","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0411","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.1016\/j.healun.2020.01.299","article-title":"Treatment and pattern of resolution of antibody-mediated rejection with hemodynamic compromise resistant to standard therapy after heart transplantation with a positive virtual crossmatch","volume":"39","author":"Mokshagundam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0412","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0413","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.01.015","article-title":"Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes","volume":"28","author":"Wu","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0414","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOT.0000000000000640","article-title":"The impact of asymptomatic antibody-mediated rejection on outcome after heart transplantation","volume":"24","author":"Kfoury","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0415","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03910.x","article-title":"Development of donor-specific isohemagglutinins following pediatric abo-incompatible heart transplantation: isohemagglutinins and heart transplant","volume":"12","author":"Conway","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0416","doi-asserted-by":"crossref","first-page":"e13332","DOI":"10.1111\/petr.13332","article-title":"Donor-specific anti-HLA antibody production following pediatric ABO-incompatible heart transplantation","volume":"23","author":"Chen","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0417","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-6143.2009.02877.x","article-title":"Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?: absence of DSA in ABOi-heart transplantation","volume":"10","author":"Urschel","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0418","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.13071","article-title":"Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis","volume":"15","author":"Feingold","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0419","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.healun.2003.09.016","article-title":"Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up","volume":"23","author":"Dobbels","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ehf2.12107","article-title":"The impact of gender mismatching on early and late outcomes following heart transplantation","volume":"4","author":"Peled","year":"2017","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0421","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/ctr.12998","article-title":"Acute cellular rejection later than one year after heart transplantation: a single-center retrospective study at Sk\u00e5ne University Hospital in Lund 1988-2010","volume":"31","author":"S\u00f6derlund","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0422","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2015.08.008","article-title":"Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation","volume":"35","author":"Tran","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0423","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1111\/ajt.13386","article-title":"High risk of graft failure in emerging adult heart transplant recipients: high-risk window in heart transplant","volume":"15","author":"Foster","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0424","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/TP.0000000000001152","article-title":"Reported nonadherence to immunosuppressive medication in young adults after heart transplantation: a retrospective analysis of a national registry","volume":"101","author":"Tumin","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0425","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/ajt.15590","article-title":"Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients","volume":"20","author":"Boucquemont","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0426","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13346","article-title":"Medication adherence in pediatric renal transplant patients: the role of family functioning and parent health locus of control","volume":"23","author":"Kraenbring","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0427","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13647","article-title":"Generalized and specific anxiety in adolescents following heart transplant","volume":"24","author":"McCormick","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0428","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cardfail.2019.06.011","article-title":"Pediatric heart transplantation: transitioning to adult care (TRANSIT): feasibility of a pilot randomized controlled trial","volume":"25","author":"Grady","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0429","doi-asserted-by":"crossref","unstructured":"Danziger-Isakov L, Frazier TW, Worley S, et al. Perceived barriers to medication adherence remain stable following solid organ transplantation. Pediatr Transplant 2019;23:1-14.","DOI":"10.1111\/petr.13361"},{"key":"10.1016\/j.healun.2022.10.015_bib0430","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/TXD.0000000000000842","article-title":"Pediatric outcomes in transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): the Collaboration and Design of a National Transplant Precision Medicine Program","volume":"4","author":"Papaz","year":"2018","journal-title":"Transpl Direct"},{"key":"10.1016\/j.healun.2022.10.015_bib0431","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2015.03.002","article-title":"Late antibody-mediated rejection after heart transplantation: mortality, graft function, and fulminant cardiac allograft vasculopathy","volume":"34","author":"Coutance","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0432","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1600-6143.2011.03563.x","article-title":"Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy: very late heart transplant rejection","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0433","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.healun.2013.05.012","article-title":"Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation","volume":"32","author":"Tible","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0434","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ejhf.886","article-title":"Late graft failure in heart transplant recipients: incidence, risk factors and clinical outcomes: heart failure after heart transplantation","volume":"20","author":"L\u00f3pez-Sainz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0435","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.transproceed.2018.06.022","article-title":"Comparative study of pediatric coronary allograft vasculopathy between single centers in North America and United Kingdom","volume":"50","author":"Fenton","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0436","first-page":"2492","article-title":"Optical coherence tomography for the early detection of coronary vascular changes in children and adolescents after cardiac transplantation","volume":"12","author":"McGovern","year":"2019","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0437","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40472-015-0081-6","article-title":"Update on immune monitoring in heart transplantation","volume":"2","author":"Crespo-Leiro","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0438","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/23808993.2021.1840273","article-title":"The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care","volume":"6","author":"Deng","year":"2021","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"10.1016\/j.healun.2022.10.015_bib0439","doi-asserted-by":"crossref","unstructured":"Khanna R. Immune monitoring of infectious complications in transplant patients: an important step towards improved clinical management. J Clin Microbiol 2018;56:1-6.","DOI":"10.1128\/JCM.02009-17"},{"key":"10.1016\/j.healun.2022.10.015_bib0440","first-page":"129","article-title":"A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial","volume":"4","author":"Baran","year":"2011","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0441","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.10.015_bib0442","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","article-title":"Heart transplantation for end-stage heart failure due to cardiac sarcoidosis","volume":"45","author":"Perkel","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0443","first-page":"978","article-title":"Invasive hemodynamics and rejection rates in patients with cardiac sarcoidosis after heart transplantation","volume":"34","author":"Rosenthal","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0444","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/eci.11.84","article-title":"Therapy for sarcoidosis: evidence-based recommendations","volume":"8","author":"Baughman","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0445","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match","volume":"38","author":"Rossano","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0446","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.healun.2015.03.003","article-title":"Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: a propensity matched analysis of the Pediatric Heart Transplant Study database","volume":"34","author":"Auerbach","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0447","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.healun.2019.06.006","article-title":"Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: a multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04)","volume":"38","author":"Lamour","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0448","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.TP.0000437433.35227.77","article-title":"Steroid avoidance in pediatric heart transplantation results in excellent graft survival","volume":"97","author":"Auerbach","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0449","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/TP.0b013e3181fd01b7","article-title":"Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial","volume":"90","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0450","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0451","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2013.11.036","article-title":"Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?","volume":"171","author":"Gonzalez-Vilchez","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0452","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0453","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0454","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0455","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/ajt.12833","article-title":"Sirolimus conversion after heart transplant: risk factors for acute rejection and predictors of renal function response","volume":"14","author":"Zuckermann","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0456","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1097\/TP.0000000000001706","article-title":"Effect of calcineurin inhibitor-free, everolimus-based immunosuppressive regimen on albuminuria and glomerular filtration rate after heart transplantation","volume":"101","author":"Nelson","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0457","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study","volume":"19","author":"Barten","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0458","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2016.02.075","article-title":"Wound complications and surgical events in de novo heart transplant patients treated with everolimus: post-hoc analysis of the SCHEDULE trial","volume":"210","author":"Rashidi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0459","first-page":"111","article-title":"Strategies in immunosuppression after heart transplantation: is less better?","volume":"4","author":"Kobashigawa","year":"2011","journal-title":"Circulation: Heart Failure"},{"key":"10.1016\/j.healun.2022.10.015_bib0460","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1016\/j.healun.2015.01.915","article-title":"Single drug immunosuppression for heart transplant recipients <2 years of age results in acceptable outcomes","volume":"34","author":"Stack","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0461","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1399-3046.2011.01566.x","article-title":"Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients","volume":"15","author":"Chinnock","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0462","doi-asserted-by":"crossref","unstructured":"Asante-Korang A, Carapellucci J, Krasnopero D, Doyle A, Brown B, Amankwah E. Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation. Clin Transplant 2017;31:1-7.","DOI":"10.1111\/ctr.13054"},{"key":"10.1016\/j.healun.2022.10.015_bib0463","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.12808","article-title":"Calcineurin inhibitor- and corticosteroid-free immunosuppression in pediatric heart transplant patients","volume":"21","author":"Sierra","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0464","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/petr.12163","article-title":"Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients","volume":"17","author":"Loar","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0465","doi-asserted-by":"crossref","unstructured":"Almond C, Sleeper LA, J.W. Rossano JW, et al. The TEAMMATE trial: Study design and rationale of the first Pediatric Heart Transplant Randomized clinical trial. JHLT 2020;39:s207-s208.","DOI":"10.1016\/j.healun.2020.01.825"},{"key":"10.1016\/j.healun.2022.10.015_bib0466","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MD.0b013e3181dfa59c","article-title":"Infectious and non-infectious neurologic complications in heart transplant recipients","volume":"89","author":"Munoz","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.healun.2022.10.015_bib0467","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIR.0b013e318265ee8a","article-title":"Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association","volume":"126","author":"Marino","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0468","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jacc.2011.04.038","article-title":"Outcomes in patients with symptomatic cerebrovascular disease undergoing heart transplantation","volume":"58","author":"Patlolla","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0469","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5853\/jos.2015.01599","article-title":"Ischemic stroke after heart transplantation","volume":"18","author":"Acampa","year":"2016","journal-title":"J Stroke"},{"key":"10.1016\/j.healun.2022.10.015_bib0470","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.healun.2016.12.010","article-title":"Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices","volume":"36","author":"Frontera","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0471","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.athoracsur.2012.01.059","article-title":"Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices","volume":"93","author":"Arnaoutakis","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0472","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2013.05.072","article-title":"Outcomes of heart transplantation in small children bridged with ventricular assist devices","volume":"96","author":"Kilic","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0473","series-title":". Handbook of clinical neurology","first-page":"1229","article-title":"Neurologic aspects of heart transplantation","author":"Heroux","year":"2014"},{"key":"10.1016\/j.healun.2022.10.015_bib0474","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.healun.2022.10.015_bib0475","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.healun.2022.10.015_bib0476","doi-asserted-by":"crossref","first-page":"e3173","DOI":"10.1097\/MD.0000000000003173","article-title":"Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review","volume":"95","author":"Song","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.healun.2022.10.015_bib0477","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clineuro.2010.07.023","article-title":"Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors","volume":"112","author":"Burnett","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.healun.2022.10.015_bib0478","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.transproceed.2009.01.041","article-title":"Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?","volume":"41","author":"Dzudie","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0479","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-5366-1","article-title":"Incidence and risk factors for seizures after heart transplantation","volume":"257","author":"Navarro","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.healun.2022.10.015_bib0480","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1552-6569.2007.00097.x","article-title":"Neuroimaging and neurologic complications after organ transplantation","volume":"17","author":"Zivkovic","year":"2007","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0481","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11940-012-0180-y","article-title":"Seizure treatment in transplant patients","volume":"14","author":"Shepard","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.healun.2022.10.015_bib0482","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1136\/bmj.e420","article-title":"Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study","volume":"344","author":"Van den Boogaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2022.10.015_bib0483","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ccc.2008.05.001","article-title":"Psychiatric aspects of organ transplantation in critical care","volume":"24","author":"DiMartini","year":"2008","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.healun.2022.10.015_bib0484","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.healun.2008.12.004","article-title":"Neuromuscular diseases after cardiac transplantation","volume":"28","author":"Mateen","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0485","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1053-2498(01)00300-X","article-title":"Acute quadriplegic myopathy with loss of thick (myosin) filaments following heart transplantation","volume":"20","author":"Perea","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0486","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archneurol.2007.52","article-title":"Effect of neurologic complications on outcome after heart transplant","volume":"65","author":"van de Beek","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.healun.2022.10.015_bib0487","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.healun.2009.05.002","article-title":"Neurodevelopmental outcomes in pediatric heart transplant recipients","volume":"28","author":"Uzark","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0488","doi-asserted-by":"crossref","first-page":"425-35 e6","DOI":"10.1016\/j.ahj.2011.05.026","article-title":"Berlin Heart EXCOR pediatric ventricular assist device investigational device exemption study: study design and rationale","volume":"162","author":"Almond","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0489","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1542\/peds.111.6.e671","article-title":"Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery","volume":"111","author":"Hamrick","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2022.10.015_bib0490","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.athoracsur.2009.03.049","article-title":"Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation","volume":"87","author":"Imamura","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0491","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa1014164","article-title":"Prospective trial of a pediatric ventricular assist device","volume":"367","author":"Fraser","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0492","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MAT.0000000000001093","article-title":"Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support","volume":"66","author":"VanderPluym","year":"2019","journal-title":"ASAIO J."},{"key":"10.1016\/j.healun.2022.10.015_bib0493","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.109.1.1","article-title":"Infant heart transplantation at Stanford: growth and neurodevelopmental outcome","volume":"109","author":"Fleisher","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2022.10.015_bib0494","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.healun.2003.08.003","article-title":"A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation","volume":"23","author":"Freier","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0495","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/a0021167","article-title":"Psychological and psychosocial aspects of the solid organ transplant experience\u2013a practice review","volume":"47","author":"Rainer","year":"2010","journal-title":"Psychotherapy"},{"key":"10.1016\/j.healun.2022.10.015_bib0496","doi-asserted-by":"crossref","first-page":"e12905","DOI":"10.1111\/ctr.12905","article-title":"Psychosocial aspects before and up to 2 years after heart or lung transplantation: experience of patients and their next of kin","volume":"31","author":"\u00c5gren","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0497","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11897-014-0233-5","article-title":"The value of psychosocial factors in patient selection and outcomes after heart transplantation","volume":"12","author":"Coglianese","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0498","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.healun.2006.11.013","article-title":"Parenting stress and parental post-traumatic stress disorder in families after pediatric heart transplantation","volume":"26","author":"Farley","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0499","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2010.10.001","article-title":"Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment","volume":"33","author":"Favaro","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.healun.2022.10.015_bib0500","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1542\/peds.2004-0118","article-title":"Traumatic stress symptoms in adolescent organ transplant recipients","volume":"115","author":"Mintzer","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2022.10.015_bib0501","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0502","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0503","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.healun.2011.12.006","article-title":"Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature","volume":"31","author":"Prada-Delgado","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0504","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.healun.2019.08.005","article-title":"Long-term outcome of cardiac allograft vasculopathy: importance of the International Society for Heart and Lung Transplantation angiographic grading scale","volume":"38","author":"Van Keer","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0505","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/TP.0b013e31821ab91b","article-title":"Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis","volume":"91","author":"Yamasaki","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0506","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.healun.2015.01.990","article-title":"Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation","volume":"34","author":"Potena","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0507","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.healun.2017.10.014","article-title":"Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study","volume":"37","author":"Clemmensen","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0508","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.healun.2018.04.002","article-title":"Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis","volume":"37","author":"Pazdernik","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0509","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.healun.2013.02.005","article-title":"Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study)","volume":"32","author":"Khandhar","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0510","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jcmg.2016.10.021","article-title":"Layered fibrotic plaques are the predominant component in cardiac allograft vasculopathy: systematic findings and risk stratification by OCT","volume":"10","author":"Clemmensen","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0511","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/TP.0000000000002983","article-title":"Association of clinical rejection versus rejection on protocol biopsy with cardiac allograft vasculopathy in pediatric heart transplant recipients","volume":"104","author":"Asimacopoulos","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0512","doi-asserted-by":"crossref","unstructured":"Nandi D, Chin C, Schumacher KR, et al. Surveillance for cardiac allograft vasculopathy: practice variations among 50 pediatric heart transplant centers. J Heart Lung Transplant 2020;39:1260-1269.","DOI":"10.1016\/j.healun.2020.08.003"},{"key":"10.1016\/j.healun.2022.10.015_bib0513","first-page":"759","article-title":"Clinical and functional correlates of early microvascular dysfunction after heart transplantation","volume":"5","author":"Haddad","year":"2012","journal-title":"Circ"},{"key":"10.1016\/j.healun.2022.10.015_bib0514","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/CIRCULATIONAHA.116.025268","article-title":"Coronary endothelial dysfunction and the index of microcirculatory resistance as a marker of subsequent development of cardiac allograft vasculopathy","volume":"135","author":"Lee","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0515","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.115.018741","article-title":"Invasive assessment of coronary physiology predicts late mortality after heart transplantation","volume":"133","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0516","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.healun.2014.11.019","article-title":"Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: diagnostic accuracy and predictors of outcomes","volume":"34","author":"Chirakarnjanakorn","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0517","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.healun.2016.05.012","article-title":"Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0518","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2011.12.014","article-title":"Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience","volume":"31","author":"Chen","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0519","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2014.07.008","article-title":"Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy","volume":"34","author":"Clemmensen","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.echo.2014.01.020","article-title":"Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy","volume":"27","author":"Sade","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2022.10.015_bib0521","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ajt.13108","article-title":"Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography","volume":"15","author":"Tona","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0522","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12350-009-9166-x","article-title":"Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients","volume":"17","author":"Manrique","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0523","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ejechocard\/jer270","article-title":"Single photon emission computed tomography myocardial perfusion imaging to detect cardiac allograft vasculopathy","volume":"13","author":"Thompson","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0524","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/TP.0000000000003791","article-title":"Clinical utility of SPECT in the heart transplant population: analysis from a single large-volume center","volume":"106","author":"Aguilar","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0525","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehx683","article-title":"Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy","volume":"39","author":"Bravo","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0526","article-title":"Reduced myocardial flow reserve by positron emission tomography predicts cardiovascular events after cardiac transplantation","volume":"11","author":"Konerman","year":"2018","journal-title":"Circ"},{"key":"10.1016\/j.healun.2022.10.015_bib0527","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2018.01.062","article-title":"PET assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy","volume":"71","author":"Chih","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0528","doi-asserted-by":"crossref","unstructured":"Chih S, Chong AY, Bernick J, et al. Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance. J Nucl Cardiol 2020;28:2286-2298.","DOI":"10.1007\/s12350-020-02038-y"},{"key":"10.1016\/j.healun.2022.10.015_bib0529","first-page":"12","article-title":"Serial assessment of coronary flow reserve by rubidium-82 positron emission tomography predicts mortality in heart transplant recipients","volume":"12","author":"Feher","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0530","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2967\/jnumed.119.229625","article-title":"Comparative prognostic and diagnostic value of myocardial blood flow and myocardial flow reserve after cardiac transplant","volume":"61","author":"Miller","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0531","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2013.07.119","article-title":"Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy","volume":"63","author":"Miller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0532","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1111\/ajt.13839","article-title":"Perfusion cardiac magnetic resonance imaging as a rule-out test for cardiac allograft vasculopathy","volume":"16","author":"Chih","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0533","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcmg.2015.10.012","article-title":"Myocardial perfusion reserve and strain-encoded CMR for evaluation of cardiac allograft microvasculopathy","volume":"9","author":"Erbel","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0534","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/ehjci\/jeu090","article-title":"Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy","volume":"15","author":"Braggion-Santos","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCIMAGING.112.975797","article-title":"Detection and grading of coronary allograft vasculopathy in children with contrast-enhanced magnetic resonance imaging of the coronary vessel wall","volume":"6","author":"Hussain","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0536","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009060","article-title":"Myocardial fibrosis and prognosis in heart transplant recipients","volume":"12","author":"Hughes","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0537","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Reeder SB and International Society for Magnetic Resonance in M. Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.healun.2022.10.015_bib0538","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2014.01.071","article-title":"Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials","volume":"63","author":"Wever-Pinzon","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0539","doi-asserted-by":"crossref","unstructured":"RJH Miller RJH, Kwiecinski J, Shah KS, et al. Coronary computed tomography-angiography quantitative plaque analysis improves detection of early cardiac allograft vasculopathy: a pilot study. Am J Transplant 2019;20:1375-1383.","DOI":"10.1111\/ajt.15721"},{"key":"10.1016\/j.healun.2022.10.015_bib0540","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcct.2018.11.006","article-title":"Quantitative CT assessment identifies more heart transplanted patients with progressive coronary wall thickening than standard clinical read","volume":"13","author":"Karolyi","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.healun.2022.10.015_bib0541","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2016.09.013","article-title":"Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients","volume":"36","author":"Daly","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0542","doi-asserted-by":"crossref","unstructured":"Starling RC, Stehlik J, Baran DA, et al. Multicenter analysis of immune biomarkers and heart transplant outcomes: results of the clinical trials in organ transplantation-05 study. Am J Transplant 2015;16:121-36.","DOI":"10.1111\/ajt.13422"},{"key":"10.1016\/j.healun.2022.10.015_bib0543","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.healun.2018.04.015","article-title":"Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children","volume":"37","author":"Watanabe","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0544","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo heart transplant recipients. Three-year results of a scandinavian randomized trial","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0545","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jchf.2013.07.002","article-title":"Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial","volume":"1","author":"Kobashigawa","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0546","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jchf.2013.07.002","article-title":"Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial","volume":"1","author":"Kobashigawa","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0547","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/ajt.13214","article-title":"The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a scandinavian randomized trial","volume":"15","author":"Arora","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0548","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2018.03.111","article-title":"Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis","volume":"265","author":"Jennings","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0549","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"verolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0550","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.healun.2013.05.015","article-title":"Attenuation of cardiac allograft vasculopathy by sirolimus: relationship to time interval after heart transplantation","volume":"32","author":"Matsuo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0551","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/ajt.12208","article-title":"Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice","volume":"13","author":"Masetti","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0552","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40472-014-0035-4","article-title":"Use of proliferation signal inhibitors in cardiac transplantation","volume":"1","author":"Eisen","year":"2014","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0553","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jchf.2014.01.003","article-title":"Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention","volume":"2","author":"Agarwal","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0554","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.healun.2014.11.011","article-title":"Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: a multi-institutional study","volume":"34","author":"Jeewa","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0555","first-page":"962","article-title":"Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature","volume":"77","author":"Dasari","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.healun.2022.10.015_bib0556","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.healun.2009.08.020","article-title":"Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease","volume":"29","author":"Beygui","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0557","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.921266","article-title":"Everolimus-eluting second-generation stents for treatment of de novo lesions in patients with cardiac allograft vasculopathy","volume":"25","author":"Pyka","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0558","first-page":"48","article-title":"Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy","volume":"90","author":"Cheng","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.healun.2022.10.015_bib0559","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.amjcard.2018.01.025","article-title":"Role of percutaneous coronary intervention in the treatment of cardiac allograft vasculopathy","volume":"121","author":"Lee","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0560","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.healun.2014.09.010","article-title":"First experience with paclitaxel-coated balloon angioplasty in patients with adult transplant coronary artery disease: is it an alternative to drug-eluting stents?","volume":"34","author":"Brenot","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0561","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2016.02.001","article-title":"Treatment of focal transplant vasculopathy with a bioresorbable coronary artery stent","volume":"35","author":"Kamdar","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0562","first-page":"e13762","article-title":"Donor history of malignancy: a limited risk for heart transplant recipients","author":"Rudasill","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0563","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/TP.0000000000000563","article-title":"Pretransplant malignancy as a risk factor for posttransplant malignancy after heart transplantation","volume":"99","author":"Yoosabai","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0564","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/j.1600-6143.2012.04197.x","article-title":"A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients","volume":"12","author":"Chinnock","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0565","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/ajt.15358","article-title":"Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization","volume":"19","author":"L'Huillier","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0566","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0567","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.trim.2015.04.003","article-title":"Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: an update","volume":"32","author":"Hertig","year":"2015","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0568","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0569","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0570","first-page":"427","article-title":"Adoptive T-Cell Immunotherapy","volume":"391","author":"Gottschalk","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.healun.2022.10.015_bib0571","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","article-title":"Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial","volume":"35","author":"Trappe","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.healun.2022.10.015_bib0572","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1182\/blood.V124.21.4468.4468","article-title":"Response-adapted sequential immuno-chemotherapy of post-transplant lymphoproliferative disorders in pediatric solid organ transplant recipients: results from the prospective Ped-PTLD 2005 trial","volume":"124","author":"Maecker-Kolhoff","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.healun.2022.10.015_bib0573","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jacc.2017.10.077","article-title":"Temporal trends of de novo malignancy development after heart transplantation","volume":"71","author":"Youn","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0574","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR Inhibitors in Transplant Recipients","volume":"101","author":"de Fijter","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0575","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI121127","article-title":"Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation","volume":"130","author":"Prockop","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.10.015_bib0576","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific t cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.healun.2022.10.015_bib0577","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0578","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.healun.2016.05.028","article-title":"Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: an analysis of the UNOS database","volume":"35","author":"Habib","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0579","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jtcvs.2014.05.065","article-title":"An easily calculable and highly predictive risk index for postoperative renal failure after heart transplantation","volume":"148","author":"Kilic","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0580","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0581","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.healun.2011.08.012","article-title":"Histopathology of renal failure after heart transplantation: a diverse spectrum","volume":"31","author":"Pinney","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0582","doi-asserted-by":"crossref","first-page":"e13414","DOI":"10.1111\/ctr.13414","article-title":"Longitudinal changes in kidney function following heart transplantation: stanford experience","volume":"32","author":"Taiwo","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0583","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0584","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dbi20-0040","article-title":"SGLT2 Inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the national kidney foundation","volume":"70","author":"Tuttle","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.healun.2022.10.015_bib0585","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.healun.2010.01.005","article-title":"Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation","volume":"29","author":"Gude","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0586","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2007.07.034","article-title":"Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction","volume":"26","author":"Gustafsson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0587","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","article-title":"De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation\u20138-year results","volume":"34","author":"Guethoff","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0588","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","article-title":"Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference","volume":"99","author":"Babitt","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.healun.2022.10.015_bib0589","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.healun.2016.08.004","article-title":"Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation","volume":"36","author":"Grupper","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0590","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ehf2.12585","article-title":"Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival","volume":"7","author":"Roest","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0591","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0b013e3181c42248","article-title":"Kidney transplantation in patients with a prior heart transplant","volume":"89","author":"Cassuto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0592","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trre.2015.02.004","article-title":"The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review","volume":"29","author":"Viswesh","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.healun.2022.10.015_bib0593","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/j.ajkd.2014.12.020","article-title":"BK virus nephropathy in heart transplant recipients","volume":"65","author":"Joseph","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0594","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.healun.2010.08.028","article-title":"BK virus in heart transplant recipients: a prospective study","volume":"30","author":"Loeches","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0595","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2014.09.043","article-title":"Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients","volume":"34","author":"Ducharme-Smith","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0596","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/nep.12728","article-title":"BK virus nephropathy in renal transplant recipients","volume":"21","author":"Jamboti","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.healun.2022.10.015_bib0597","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.transproceed.2015.05.010","article-title":"BK virus nephropathy in kidney transplantation: an approach proposal and update on risk factors, diagnosis, and treatment","volume":"47","author":"Gonzalez","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0598","doi-asserted-by":"crossref","first-page":"e13477","DOI":"10.1111\/petr.13477","article-title":"Renal injury and recovery in pediatric patients after ventricular assist device implantation and cardiac transplant","volume":"23","author":"Hollander","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0599","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.healun.2018.06.016","article-title":"Changes in renal function after left ventricular assist device placement in pediatric patients: a pedimacs analysis","volume":"37","author":"Friedland-Little","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0600","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/ajt.14638","article-title":"Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients","volume":"18","author":"Williams","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0601","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1399-3046.2011.01564.x","article-title":"Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study","volume":"15","author":"Feingold","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0602","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.healun.2017.09.027","article-title":"End-stage renal disease after pediatric heart transplantation: a 25-year national cohort study","volume":"37","author":"Choudhry","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0603","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc21-Sint","article-title":"Introduction: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.healun.2022.10.015_bib0604","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.healun.2017.06.009","article-title":"Metformin therapy reduces the risk of malignancy after heart transplantation","volume":"36","author":"Peled","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-019-0925-y","article-title":"Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation","volume":"18","author":"Ram","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.healun.2022.10.015_bib0606","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0607","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.healun.2022.10.015_bib0608","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0609","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.120.051824","article-title":"Effect of empagliflozin on cardiovascular and renal outcomes in patients with heart failure by baseline diabetes status: results from the EMPEROR-reduced trial","volume":"143","author":"Anker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0610","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2017.05.005","article-title":"Empagliflozin in the management of diabetes mellitus after cardiac transplantation Research Correspondenceretain\u2013>","volume":"36","author":"Muir","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0611","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.healun.2021.02.012","article-title":"Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence","volume":"40","author":"Sammour","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0612","doi-asserted-by":"crossref","unstructured":"Warden BA, Duell PB. Management of dyslipidemia in adult solid organ transplant recipients. J Clin Lipidol 2019;13:231-245.","DOI":"10.1016\/j.jacl.2019.01.011"},{"key":"10.1016\/j.healun.2022.10.015_bib0613","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.healun.2011.07.002","article-title":"Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: a pilot, randomized, intravascular ultrasound study","volume":"30","author":"Potena","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0614","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ehf2.12329","article-title":"Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients","volume":"5","author":"Asleh","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0615","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.10.015_bib0616","first-page":"104.e1","article-title":"Safety and efficacy of PCSK9 inhibitors after heart transplantation","volume":"35","author":"Moayedi","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0617","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacl.2019.06.010","article-title":"PCSK9 inhibition in patients with heart transplantation: a case series","volume":"13","author":"Sandesara","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.healun.2022.10.015_bib0618","doi-asserted-by":"crossref","unstructured":"Di Nora C, Sponga S and Livi U. Safety and efficacy of PCSK9 inhibitor treatment in heart transplant patients. 2019;103:e58","DOI":"10.1097\/TP.0000000000002520"},{"key":"10.1016\/j.healun.2022.10.015_bib0619","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/TP.0000000000002944","article-title":"PCSK9 Inhibitor use in heart transplant recipients: a case series and review of the literature","volume":"104","author":"Jennings","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0620","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1177\/1060028013504077","article-title":"An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors","volume":"47","author":"Makkar","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.healun.2022.10.015_bib0621","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cardfail.2021.02.018","article-title":"PCSK9 inhibitors in heart transplant patients: safety, efficacy, and angiographic correlates","volume":"27","author":"Sammour","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0622","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2022.10.015_bib0623","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jacl.2018.05.007","article-title":"Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: rationale and design of the HAUSER-RCT study","volume":"12","author":"Gaudet","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.healun.2022.10.015_bib0624","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.healun.2008.02.014","article-title":"Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients","volume":"27","author":"Quarta","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0625","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the american heart association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0626","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0627","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Hoskova","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0628","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0629","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2020.01.003","article-title":"Long-term clinical outcomes with use of an angiotensin-converting enzyme inhibitor early after heart transplantation","volume":"222","author":"Arashi","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0630","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.jacc.2017.03.598","article-title":"Angiotensin-converting enzyme inhibition early after heart transplantation","volume":"69","author":"Fearon","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0631","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176220","article-title":"NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity","volume":"12","author":"Tutakhel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2022.10.015_bib0632","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.healun.2017.06.015","article-title":"Early aspirin use and the development of cardiac allograft vasculopathy","volume":"36","author":"Kim","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0633","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.13133","article-title":"Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up","volume":"31","author":"Peled","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0634","unstructured":"Corporation OHIR. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0635","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0636","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9149(01)01641-1","article-title":"Increased incidence of atrial flutter associated with the rejection of heart transplantation","volume":"88","author":"Cui","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0637","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2010.04.035","article-title":"Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation","volume":"106","author":"Dasari","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0638","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2008.02.065","article-title":"Supraventricular tachycardia after orthotopic cardiac transplantation","volume":"51","author":"Vaseghi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0639","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/europace\/eus064","article-title":"Conductor externalization of the Riata internal cardioverter defibrillator lead: tip of the iceberg? Report of three cases and review of literature","volume":"14","author":"Dorman","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.healun.2022.10.015_bib0640","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jce.12078","article-title":"Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes","volume":"24","author":"Nof","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0641","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0642","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.CIR.81.3.821","article-title":"Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity","volume":"81","author":"Ellenbogen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0643","first-page":"II273","article-title":"Sudden cardiac death in cardiac transplant recipients","volume":"94","author":"Patel","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0644","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1053-2498(03)00295-X","article-title":"Sudden, unexpected death in cardiac transplant recipients: an autopsy study","volume":"23","author":"Chantranuwat","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0645","doi-asserted-by":"crossref","first-page":"e13490","DOI":"10.1111\/ctr.13490","article-title":"The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry","volume":"33","author":"Alba","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0646","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc3001.093501","article-title":"Clinical implications for affected parents and siblings of probands with long-QT syndrome","volume":"104","author":"Kimbrough","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0647","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.healun.2011.08.015","article-title":"Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group","volume":"30","author":"Daly","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0648","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2009.01.005","article-title":"Mode and mechanisms of death after orthotopic heart transplantation","volume":"6","author":"Vaseghi","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.healun.2022.10.015_bib0649","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.healun.2015.12.011","article-title":"Implantable cardioverter-defibrillators in a heart transplant population: a single-center experience","volume":"35","author":"Neylon","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0650","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0651","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2009.01.011","article-title":"Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators","volume":"28","author":"Marzoa-Rivas","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0652","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCHEARTFAILURE.108.814525","article-title":"The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry","volume":"2","author":"Tsai","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0653","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1540-8159.2010.02906.x","article-title":"Permanent pacing for late-onset atrioventricular block in patients with heart transplantation: a single center experience","volume":"34","author":"Tay","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0654","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.healun.2011.05.010","article-title":"Permanent pacemaker implantation early and late after heart transplantation: clinical indication, risk factors and prognostic implications","volume":"30","author":"Jones","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0655","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pace.13021","article-title":"A single center study of 1,179 heart transplant patients\u2014factors affecting pacemaker implantation","volume":"40","author":"Wellmann","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0656","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0002-9149(96)00482-1","article-title":"Bradycardia: a late complication following cardiac transplantation","volume":"78","author":"Weinfeld","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0657","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1540-8159.1996.tb03334.x","article-title":"Atrioventricular block occurring late after heart transplantation: presentation of three cases and literature review","volume":"19","author":"Cataldo","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0658","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0659","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0660","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0661","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0662","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.015_bib0663","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17512433.2019.1637733","article-title":"Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy","volume":"12","author":"Lam","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.healun.2022.10.015_bib0664","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/ctr.12873","article-title":"Direct oral anticoagulant considerations in solid organ transplantation: a review","volume":"31","author":"Salerno","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0665","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/TP.0000000000000223","article-title":"Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A","volume":"98","author":"Wannhoff","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0666","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1016\/j.ijcard.2013.06.148","article-title":"Anticoagulation with a new oral anticoagulant in heart transplant recipients","volume":"168","author":"Ambrosi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0667","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cts.12580","article-title":"Drug-drug interaction study of apixaban with cyclosporine and tacrolimus in healthy volunteers","volume":"11","author":"Bashir","year":"2018","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.healun.2022.10.015_bib0668","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FTD.0000000000000356","article-title":"Effect of the direct oral anticoagulants rivaroxaban and apixaban on the disposition of calcineurin inhibitors in transplant recipients","volume":"39","author":"Vanhove","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.healun.2022.10.015_bib0669","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1526924816661951","article-title":"Evaluation of direct oral anticoagulation therapy in heart and lung transplant recipients","volume":"26","author":"Lichvar","year":"2016","journal-title":"Prog Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0670","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.healun.2019.12.007","article-title":"Use of direct oral anticoagulants after heart transplantation","volume":"39","author":"Henricksen","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0671","doi-asserted-by":"crossref","first-page":"e14396","DOI":"10.1111\/ctr.14396","article-title":"Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients","volume":"35","author":"Salerno","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0672","first-page":"640","article-title":"Risk of major bleeding in solid organ transplant recipients taking calcineurin inhibitors concomitantly with direct oral anticoagulants compared to warfarin","volume":"17","author":"Hazelcorn","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0673","first-page":"404","article-title":"Novel oral anticoagulants in kidney transplantation: results from a multicenter prospective pilote study","volume":"32","author":"Leon","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0674","first-page":"1109","article-title":"Safety and efficacy of anti Xa inhibitors post-transplant with concomitant calcineurin inhibitors","volume":"19","author":"McMurry","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0675","first-page":"415","article-title":"The comparative safety and efficacy of direct acting oral anticoagulants relative to warfarin following liver transplantation","volume":"19","author":"Santeusanio","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0676","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1016\/j.healun.2019.01.765","article-title":"Direct oral anticoagulants: an evaluation of the safety and efficacy in cardiothoracic transplant recipients","volume":"38","author":"Pasley","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0677","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.healun.2022.10.015_bib0678","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.healun.2022.10.015_bib0679","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.healun.2022.10.015_bib0680","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2019.08.002","article-title":"A multi-national trial of a direct oral anticoagulant in children with cardiac disease: design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study","volume":"217","author":"Payne","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2022.10.015_bib0681","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/rth2.12352","article-title":"The Edoxaban Hokusai VTE PEDIATRICS study: an open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease","volume":"4","author":"van Ommen","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.healun.2022.10.015_bib0682","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/TP.0000000000000584","article-title":"Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee","volume":"99","author":"Green","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0683","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0684","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6904a1","article-title":"Assessing solid organ donors and monitoring transplant recipients for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection - U.S. public health service guideline, 2020","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0685","unstructured":"OPTN. OPTN Home Page. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0686","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0687","doi-asserted-by":"crossref","first-page":"e12862","DOI":"10.1111\/tid.12862","article-title":"Screening recipients of increased risk donor organs: a multicenter retrospective study","volume":"20","author":"Ison","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0688","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/TXD.0000000000000852","article-title":"Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission","volume":"5","author":"White","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.healun.2022.10.015_bib0689","series-title":"Consell d\u2019Europa, eds. Guide to the quality and safety of organs for transplantation","year":"2018"},{"key":"10.1016\/j.healun.2022.10.015_bib0690","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0691","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/ajt.15393","article-title":"Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors","volume":"19","author":"Jones","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0692","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/tri.13086","article-title":"Organ transplantation from \"increased infectious risk donors\": the experience of the Nord Italia Transplant program - A retrospective study","volume":"31","author":"Grossi","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0693","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jtcvs.2018.08.120","article-title":"Impact of \"increased-risk\" donor hearts on transplant outcomes: a propensity-matched analysis","volume":"157","author":"Shudo","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0694","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.healun.2014.06.005","article-title":"Centers for disease control \"high-risk\" donor status does not significantly affect recipient outcome after heart transplantation in children","volume":"33","author":"Sahulee","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0695","doi-asserted-by":"crossref","first-page":"e13370","DOI":"10.1111\/ctr.13370","article-title":"Donor-derived hepatitis C in the era of increasing intravenous drug use: a report of the disease transmission advisory committee","volume":"32","author":"Kaul","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0696","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15352","article-title":"Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017","author":"Bixler","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0697","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40472-018-0192-y","article-title":"The new direct antiviral agents and hepatitis C in thoracic transplantation: impact on donors and recipients","volume":"5","author":"Gottlieb","year":"2018","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0698","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1111\/ajt.13356","article-title":"Landscape of deceased donors labeled increased risk for disease transmission under new guidelines","volume":"15","author":"Kucirka","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0699","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses - United States, 2010-2017","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0700","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/TP.0000000000001673","article-title":"The \"PHS increased risk\" label is associated with nonutilization of hundreds of organs per year","volume":"101","author":"Volk","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0701","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/TP.0000000000001716","article-title":"Deceased organ donors and phs risk identification: impact on organ usage and outcomes","volume":"101","author":"Pruett","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0702","doi-asserted-by":"crossref","first-page":"182","DOI":"10.12659\/AOT.889680","article-title":"The impact of hepatitis B on heart transplantation: 19 years of national experience in Korea","volume":"19","author":"Shin","year":"2014","journal-title":"Ann Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0703","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.transproceed.2012.03.040","article-title":"Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation","volume":"44","author":"Chen","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0704","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0705","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/TP.0b013e3181b4e1fd","article-title":"Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database","volume":"88","author":"Dhillon","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0706","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transproceed.2010.09.094","article-title":"Donors positive for hepatitis B core antibodies in nonliver transplantations","volume":"43","author":"Salvadori","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0707","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/TP.0b013e3181b447cc","article-title":"Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the UNOS database","volume":"88","author":"Large","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0708","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.transproceed.2004.12.041","article-title":"Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study","volume":"37","author":"De Feo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0709","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/01.tp.0000264551.41668.4e","article-title":"Effectiveness of posttransplant prophylaxis with anti-hepatitis B virus immunoglobulin in recipients of heart transplant from hepatitis B virus core antibody positive donors","volume":"83","author":"Krassilnikova","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0710","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2022.10.015_bib0711","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.healun.2018.06.012","article-title":"Cardiac transplantation from non-viremic hepatitis C donors","volume":"37","author":"Patel","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0712","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0713","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15311","article-title":"[Epub ahead of print] Transplanting hepatitis C virus-infected hearts into uninfected recipients: a single-arm trial","author":"McLean RC","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0714","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.healun.2022.10.015_bib0715","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014495","article-title":"Outcomes of adult heart transplantation using hepatitis C-positive donors","volume":"9","author":"Kilic","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.10.015_bib0716","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMe1901957","article-title":"Organs from hepatitis C virus-positive donors","volume":"380","author":"Blumberg","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0717","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtcvs.2019.02.024","article-title":"Using hepatitis C and B virus-infected donor organs for pediatric heart transplantation","volume":"158","author":"Radzi","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0718","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.healun.2019.09.011","article-title":"Heart or lung transplant outcomes in HIV-infected recipients","volume":"38","author":"Koval","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0719","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/ajt.15257","article-title":"Outcomes of heart transplantation in patients with human immunodeficiency virus","volume":"19","author":"Madan","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0720","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation\u2013results at 3 to 5 years","volume":"372","author":"Muller","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0721","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/ajt.13344","article-title":"Challenges and clinical decision-making in HIV-to-HIV transplantation: insights from the HIV literature","volume":"15","author":"Boyarsky","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0722","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-0691.2008.02091.x","article-title":"Prevention of toxoplasmosis in transplant patients","volume":"14","author":"Derouin","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2022.10.015_bib0723","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2007.07.068","article-title":"Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality","volume":"50","author":"Arora","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0724","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1432-2277.2009.00993.x","article-title":"Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation","volume":"23","author":"Doesch","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0725","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/TP.0b013e3182a9274a","article-title":"Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation","volume":"96","author":"van Hellemond","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0726","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","article-title":"Diagnosis of toxoplasmosis and typing of Toxoplasma gondii","volume":"8","author":"Liu","year":"2015","journal-title":"Parasit Vectors"},{"issue":"Suppl 1","key":"10.1016\/j.healun.2022.10.015_bib0727","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1086\/338827","article-title":"Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis","volume":"185","author":"Montoya","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0728","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1432-2277.1992.tb01745.x","article-title":"Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients","volume":"5","author":"Wreghitt","year":"1992","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0729","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322733","article-title":"Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center","volume":"33","author":"Montoya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0730","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.healun.2006.08.001","article-title":"Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers","volume":"25","author":"Baran","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0731","doi-asserted-by":"crossref","first-page":"e13546","DOI":"10.1111\/ctr.13546","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0732","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005033","article-title":"Estimating the burden of chagas disease in the United States","volume":"10","author":"Manne-Goehler","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0733","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003540","article-title":"Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis","volume":"9","author":"Requena-Mendez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0734","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(10)70098-0","article-title":"Chagas disease: changes in knowledge and management","volume":"10","author":"Lescure","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0735","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QCO.0b013e3283630e4d","article-title":"Donor-derived filamentous fungal infections in solid organ transplant recipients","volume":"26","author":"Gomez","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0736","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1111\/ajt.13950","article-title":"Coccidioidomycosis transmission through organ transplantation: a report of the OPTN Ad Hoc disease transmission advisory committee","volume":"16","author":"Kusne","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0737","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2014.02.013","article-title":"Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database","volume":"147","author":"Belli","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0738","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.healun.2014.08.005","article-title":"The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric lung and heart-lung transplantation report\u20132014; focus theme: retransplantation","volume":"33","author":"Benden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0739","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.healun.2013.11.006","article-title":"Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation","volume":"33","author":"Conway","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0740","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report\u20132014; focus theme: retransplantation","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0741","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/acs.2018.01.09","article-title":"Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis","volume":"7","author":"Rizvi","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0742","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.athoracsur.2011.04.053","article-title":"Should heart transplant recipients with early graft failure be considered for retransplantation?","volume":"92","author":"Iribarne","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0743","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","article-title":"Report from a consensus conference on primary graft dysfunction after cardiac transplantation","volume":"33","author":"Kobashigawa","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0744","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/ajt.13418","article-title":"Retransplant and medical therapy for cardiac allograft vasculopathy: international society for heart and lung transplantation registry analysis","volume":"16","author":"Goldraich","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0745","doi-asserted-by":"crossref","first-page":"e13373","DOI":"10.1111\/petr.13373","article-title":"Communication about prognosis and end-of-life in pediatric organ failure and transplantation","volume":"23","author":"Cousino","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0746","article-title":"Medical and end-of-life decision making in adolescents\u2019 pre-heart transplant: a descriptive pilot study","author":"Cousino","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0747","doi-asserted-by":"crossref","first-page":"E679","DOI":"10.1111\/ctr.12250","article-title":"Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation","volume":"27","author":"Kobashigawa","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0748","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0749","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.healun.2012.07.004","article-title":"Is mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy? Analysis of the United Network of Organ Sharing database","volume":"31","author":"Khan","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0750","doi-asserted-by":"crossref","first-page":"171-181 e1","DOI":"10.1016\/j.jtcvs.2019.01.135","article-title":"Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era","volume":"158","author":"Sanchez","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0751","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/chd.12579","article-title":"Improving outpatient advance care planning for adults with congenital or pediatric heart disease followed in a pediatric heart failure and transplant clinic","volume":"13","author":"Edwards","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0752","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10741-017-9613-8","article-title":"Palliative care in cardiac transplantation: an evolving model","volume":"22","author":"Bayoumi","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0753","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.hlc.2018.10.009","article-title":"The perspectives of health care professionals on providing end of life care and palliative care for patients with chronic heart failure: an integrative review","volume":"28","author":"Singh","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.healun.2022.10.015_bib0754","unstructured":"Ethical Implications of Multi-Organ Transplants. OPTN Ethics Committee Briefing Paper. Prepared by: Abigail Fox, MPA UNOS Policy & Community Relations Department. June 11, 2019. Ethical Implications of Multi-Organ Transplants (hrsa.gov)."},{"key":"10.1016\/j.healun.2022.10.015_bib0755","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1600-6143.2010.03292.x","article-title":"Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients","volume":"10","author":"Cassuto","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0756","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/ctr.13329","article-title":"Heart and heart-liver transplantation in adults with failing Fontan physiology","volume":"32","author":"Reardon","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0757","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MOT.0000000000000509","article-title":"Conquering combined thoracic organ and liver transplantation: indications and outcomes for heart-liver and lung-liver transplantation","volume":"23","author":"Yi","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0758","doi-asserted-by":"crossref","unstructured":"Aziz H, Kim J, Kwon YK. Current state of kidney utilization in multiorgan transplants. Curr Opin Organ Transplant 2020;25:316-321.","DOI":"10.1097\/MOT.0000000000000777"},{"key":"10.1016\/j.healun.2022.10.015_bib0759","doi-asserted-by":"crossref","unstructured":"Shaw BI, Sudan DL, Boulware LE, McElroy LM. Striking a balance in simultaneous heart kidney transplant: optimizing outcomes for all wait-listed patients. J Am Soc Nephrol 2020;31:1661-1664.","DOI":"10.1681\/ASN.2020030336"},{"key":"10.1016\/j.healun.2022.10.015_bib0760","doi-asserted-by":"crossref","first-page":"e13878","DOI":"10.1111\/ctr.13878","article-title":"To kidney or not to kidney: applying lessons learned from the simultaneous liver-kidney transplant policy to simultaneous heart-kidney transplantation","volume":"34","author":"Cheng","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0761","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/ajt.16512","article-title":"Consensus conference on heart-kidney transplantation","volume":"21","author":"Kobashigawa","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0762","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.semperi.2014.04.022","article-title":"Management of pregnancy in the post-cardiac transplant patient","volume":"38","author":"Abdalla","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.healun.2022.10.015_bib0763","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/tri.13144","article-title":"Pregnancy after heart transplantation: a well-thought-out decision? The Quebec provincial experience - a multi-centre cohort study","volume":"31","author":"Dagher","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0764","doi-asserted-by":"crossref","first-page":"264","DOI":"10.6002\/ect.MESOT2018.P120","article-title":"Emergency department visits after kidney, liver, and heart transplantation in a hospital of a university in Turkey: a retrospective study","volume":"17","author":"M\u0131h\u00e7\u0131okur","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0765","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2146\/ajhp150771","article-title":"Prescribing pharmacists in the ambulatory care setting: experience at the University of North Carolina Medical Center","volume":"73","author":"Hawes","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0766","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2146\/ajhp160872","article-title":"Improvement in immunosuppression therapy monitoring in organ transplant recipients","volume":"74","author":"Thrall","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2022.10.015_bib0767","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.healun.2009.12.009","article-title":"Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study","volume":"29","author":"Gossett","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0768","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.healun.2016.08.018","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report\u20142016; Focus theme: primary diagnostic indications for transplant","volume":"35","author":"Rossano","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0769","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/acs.2018.01.07","article-title":"Current state of pediatric cardiac transplantation","volume":"7","author":"Dipchand","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0770","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0771","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ehjci\/jev139","article-title":"European Association of Cardiovascular Imaging\/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation","volume":"16","author":"Badano","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0772","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jcmg.2018.06.019","article-title":"Imaging in heart transplant patients","volume":"11","author":"Olymbios","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0773","doi-asserted-by":"crossref","first-page":"e13477","DOI":"10.1111\/ctr.13477","article-title":"Bone mineral density and osteoporosis in heart transplanted patients: a single-center retrospective study at Sk\u00e5ne University Hospital in Lund 1988-2016","volume":"33","author":"L\u00f6fdahl","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0774","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.transproceed.2012.09.117","article-title":"Bone density in heart or lung transplant recipients-a longitudinal study","volume":"45","author":"Wang","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.10.015_bib0775","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bone.2019.07.006","article-title":"Bone disease following solid organ transplantation: a narrative review and recommendations for management from The European Calcified Tissue Society","volume":"127","author":"Anastasilakis","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.healun.2022.10.015_bib0776","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1053-2498(02)01184-1","article-title":"Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients","volume":"22","author":"Braith","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0777","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/01.tp.0000176927.43937.bb","article-title":"Comparison of calcitonin versus calcitonin\u00a0+\u00a0resistance exercise as prophylaxis for osteoporosis in heart transplant recipients","volume":"81","author":"Braith","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0778","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0735-1097(96)00347-6","article-title":"Resistance exercise training restores bone mineral density in heart transplant recipients","volume":"28","author":"Braith","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0779","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0780","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jbmr.2017","article-title":"A meta-analysis of the association of fracture risk and body mass index in women: a meta-analysis of the association of fracture risk and BMI in women","volume":"29","author":"Johansson","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0781","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF01637318","article-title":"Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate","volume":"3","author":"Meys","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0782","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-3046.2009.01244.x","article-title":"Bone mineral status in pediatric heart transplant recipients: a retrospective observational study of an \u201cat risk\u201d cohort","volume":"14","author":"Sachdeva","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0783","doi-asserted-by":"crossref","first-page":"e13253","DOI":"10.1111\/petr.13253","article-title":"A 3-year longitudinal study of skeletal effects and growth in children after kidney transplantation","volume":"22","author":"Swolin-Eide","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0784","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02390832","article-title":"A meta-analysis of the effects of cigarette smoking on bone mineral density","volume":"68","author":"Ward","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0785","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.healun.2022.10.015_bib0786","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-14-0865","article-title":"Endocrinology and adolescence: osteoporosis in children: diagnosis and management","volume":"173","author":"Saraff","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.healun.2022.10.015_bib0787","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/TP.0b013e3181f6300b","article-title":"Impaired bone geometry after heart and heart-lung transplantation in childhood","volume":"90","author":"Bechtold","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0788","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/0148607115609524","article-title":"Bone mineral density and growth in children having undergone liver transplantation with corticosteroid-free immunosuppressive protocol","volume":"41","author":"Mager","year":"2017","journal-title":"J Parenteral Enteral Nutr"},{"key":"10.1016\/j.healun.2022.10.015_bib0789","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.tp.0000177645.63999.ca","article-title":"Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover","volume":"81","author":"Cohen","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0790","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1359\/jbmr.090216","article-title":"Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial*","volume":"24","author":"Fahrleitner-Pammer","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0791","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s001980170142","article-title":"Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study","volume":"12","author":"Krieg","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0792","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.1111\/ctr.13122","article-title":"Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patients","volume":"31","author":"Lange","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0793","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","article-title":"Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation","volume":"350","author":"Shane","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0794","first-page":"1","article-title":"Mechanism and treatment strategy of osteoporosis after transplantation","volume":"2015","author":"Song","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.healun.2022.10.015_bib0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.198","article-title":"Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients","volume":"46","author":"McClune","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0796","first-page":"125","article-title":"Bisphosphonate use in children with pediatric osteoporosis and other bone conditions","volume":"7","author":"Szalay","year":"2014","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0797","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1152\/jappl.1998.84.6.1967","article-title":"Cellular adaptations of skeletal muscles to cyclosporine","volume":"84","author":"Biring","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0798","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.healun.2007.09.032","article-title":"Exercise training attenuates progressive decline in brachial artery reactivity in heart transplant recipients","volume":"27","author":"Braith","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0799","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005768-199804000-00003","article-title":"Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients","volume":"30","author":"Braith","year":"1998","journal-title":"Med Sci Sports Exercise"},{"key":"10.1016\/j.healun.2022.10.015_bib0800","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1152\/jappl.1991.70.6.2627","article-title":"Cardiovascular responses of heart transplant patients to exercise training","volume":"70","author":"Keteyian","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0801","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM199901283400404","article-title":"A controlled trial of exercise rehabilitation after heart transplantation","volume":"340","author":"Kobashigawa","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0802","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00421-003-0952-x","article-title":"Exercise after heart transplantation","volume":"90","author":"Marconi","year":"2003","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0803","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00007256-199112060-00003","article-title":"Exercise and heart transplantation: a review","volume":"12","author":"Niset","year":"1991","journal-title":"Sports Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0804","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HJR.0b013e3282f0b63b","article-title":"Effects of exercise training on forearm and calf vasodilation and proinflammatory markers in recent heart transplant recipients: a pilot study","volume":"15","author":"Pierce","year":"2008","journal-title":"Eur J Cardiovasc Prevent Rehabil"},{"key":"10.1016\/j.healun.2022.10.015_bib0805","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0806","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.healun.2017.05.017","article-title":"Cardiac rehabilitation and readmissions after heart transplantation","volume":"37","author":"Bachmann","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0807","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044975","article-title":"Exercise training modalities for heart transplant recipients: a systematic review and network metaanalysis protocol","volume":"10","author":"de Lima","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.healun.2022.10.015_bib0808","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012779","article-title":"Home-based cardiac rehabilitation alone and hybrid with center-based cardiac rehabilitation in heart failure: a systematic review and meta-analysis","volume":"8","author":"Imran","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.10.015_bib0809","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000663","article-title":"Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology","volume":"140","author":"Thomas","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0810","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2018.04.030","article-title":"Mobile health advances in physical activity, fitness, and atrial fibrillation","volume":"71","author":"McConnell","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0811","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1399-3046.2007.00806.x","article-title":"Improved exercise performance in pediatric heart transplant recipients after home exercise training","volume":"12","author":"Patel","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0812","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-3046.2008.00903.x","article-title":"Exercise and the pediatric heart transplant recipient: a good thing or a bad idea?","volume":"12","author":"Quivers","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0813","series-title":"Cardiac transplantation","article-title":"Nutritional intervention in heart transplant recipients \u2013 dietary recommendations","author":"Posada-Moreno","year":"2012"},{"key":"10.1016\/j.healun.2022.10.015_bib0814","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007890-200107270-00020","article-title":"Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation","volume":"72","author":"Lietz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0815","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/SLA.0b013e3181b5db3c","article-title":"The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?","volume":"251","author":"Russo","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0816","article-title":"Exercise-based cardiac rehabilitation in heart transplant recipients","volume":"4","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0817","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology","author":"Ambrosetti","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0818","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2020.06.024","article-title":"Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: access, formulations, generics, therapeutic drug monitoring, and special populations","volume":"39","author":"Cochrane","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0819","unstructured":"Cytomegalovirus tested blood components: position statement. Available at: https:\/\/assetspublishingservicegovuk\/government\/uploads\/system\/uploads\/attachment_data\/file\/215125\/dh_133086pdf. 2012."},{"key":"10.1016\/j.healun.2022.10.015_bib0820","unstructured":"Nahirniak S, Liebermann L, Preiksaitis JK and Wall D. NAC education document: transfusion and cytomegalovirus in the Canadian blood system. 2017."},{"key":"10.1016\/j.healun.2022.10.015_bib0821","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1525-1438.2002.00069.x","article-title":"The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center","volume":"42","author":"Preiksaitis","year":"2002","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.healun.2022.10.015_bib0822","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.anclin.2017.04.009","article-title":"Anesthetic considerations in transplant recipients for nontransplant surgery","volume":"35","author":"Herborn","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.healun.2022.10.015_bib0823","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1097\/TP.0000000000001432","article-title":"Recent advances in mammalian target of rapamycin inhibitor use in heart and lung transplantation","volume":"100","author":"Fine","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0824","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1089253217706164","article-title":"Perioperative management of cardiac transplant recipients undergoing noncardiac surgery: unique challenges created by advancements in care","volume":"21","author":"Jurgens","year":"2017","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0825","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/TP.0b013e3182551021","article-title":"Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature","volume":"94","author":"Nashan","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0826","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2007.08.014","article-title":"Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation","volume":"27","author":"Zuckermann","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0827","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/TP.0000000000001060","article-title":"The safety of neuromuscular blockade reversal in patients with cardiac transplantation","volume":"100","author":"Barbara","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0828","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem-59-6-1143","article-title":"Etomidate suppresses adrenocortical function by inhibition of 1 l\u03b2-hydroxylation","volume":"59","author":"De Jong","year":"1984","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.healun.2022.10.015_bib0829","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/ACO.0b013e32834cd2f0","article-title":"Regional anesthetic procedures in immunosuppressed patients: risk of infection","volume":"24","author":"Gronwald","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0830","first-page":"621","article-title":"Time-dependent decrease of presynaptic inotropic supersensitivity: physiological evidence of sympathetic reinnervation after heart transplantation","volume":"16","author":"Koglin","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0831","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF03006323","article-title":"Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine","volume":"37","author":"Sidi","year":"1990","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.healun.2022.10.015_bib0832","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/joacp.JOACP_242_17","article-title":"Perioperative \u201cstress dose\u201d of corticosteroid: pharmacological and clinical perspective","volume":"35","author":"Chilkoti","year":"2019","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.healun.2022.10.015_bib0833","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13741-018-0092-9","article-title":"Perioperative corticosteroid administration: a systematic review and descriptive analysis","volume":"7","author":"Groleau","year":"2018","journal-title":"Perioper Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0834","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198405313102202","article-title":"Inhibition of adrenal steroidogenesis by the anesthetic etomidate","volume":"310","author":"Wagner","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0835","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breast-feeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.healun.2022.10.015_bib0836","unstructured":"Condom effectiveness. Available at: https:\/\/wwwcdcgov\/condomeffectiveness\/latexhtml. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0837","unstructured":"How to prevent sexually transmitted infections (STIs). Available at: https:\/\/wwwacogorg\/womens-health\/faqs\/how-to-prevent-stis. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0838","unstructured":"Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use. 2021."},{"key":"10.1016\/j.healun.2022.10.015_bib0839","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients: HPV vaccine in transplant","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0840","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11897-018-0392-x","article-title":"Contraceptive strategies in women with heart failure or with cardiac transplantation","volume":"15","author":"Maroo","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.healun.2022.10.015_bib0841","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.sxmr.2019.10.002","article-title":"The prevalence and treatment of erectile dysfunction in male solid organ transplant recipients","volume":"9","author":"Payne","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0842","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1432-2277.2011.01296.x","article-title":"The spectrum of nonadherence with medication in heart, liver, and lung tranplant patients assessed in various ways: nonadherence in transplant patients","volume":"24","author":"De Bleser","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0843","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/tri.12312","article-title":"Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort S","volume":"27","author":"De Geest","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0844","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/ajt.14611","article-title":"Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: the international BRIGHT study","volume":"18","author":"Denhaerynck","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0845","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/TP.0b013e3181b2a0e0","article-title":"Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation","volume":"88","author":"Dew","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0846","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/TP.0b013e3181e346cd","article-title":"The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review","volume":"90","author":"Dobbels","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0847","doi-asserted-by":"crossref","first-page":"e12899","DOI":"10.1111\/petr.12899","article-title":"Psychosocial predictors of medication adherence in pediatric heart and lung organ transplantation","volume":"21","author":"Killian","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0848","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pec.2010.04.013","article-title":"Non-adherence with drug treatment after heart or lung transplantation in adults: a systematic review","volume":"81","author":"Korb-Savoldelli","year":"2010","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.healun.2022.10.015_bib0849","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.healun.2017.02.019","article-title":"Gaining ground in efforts to promote medication adherence after organ transplantation","volume":"36","author":"Dew","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0850","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.healun.2017.01.007","article-title":"Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial","volume":"36","author":"Dobbels","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0851","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1474515117747577","article-title":"Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study","volume":"17","author":"Senft","year":"2018","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.healun.2022.10.015_bib0852","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pedhc.2017.01.010","article-title":"Maintaining the gift of life: achieving adherence in adolescent heart transplant recipients","volume":"31","author":"Steuer","year":"2017","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.healun.2022.10.015_bib0853","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1526924817699959","article-title":"Adherence of heart transplant recipients to prescribed medication and recommended lifestyle habits: a single-center experience","volume":"27","author":"Brocks","year":"2017","journal-title":"Prog Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0854","doi-asserted-by":"crossref","first-page":"e13280","DOI":"10.1111\/ctr.13280","article-title":"The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: findings from the cross-sectional BRIGHT study","volume":"32","author":"Helmy","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0855","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2017.02.023","article-title":"Transitioning from pediatric to adult care after thoracic transplantation","volume":"36","author":"Putschoegl","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0856","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.healun.2018.01.1295","article-title":"Incidence, risk factors, and clinical implications of post-operative delirium in lung transplant recipients","volume":"37","author":"Anderson","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0857","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/TP.0b013e31829584e0","article-title":"Mental health disorders and solid-organ transplant recipients","volume":"96","author":"Corbett","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0858","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.amjcard.2015.11.065","article-title":"Prevalence and correlates of post-traumatic stress disorder in adults with congenital heart disease","volume":"117","author":"Deng","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0859","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.mot.0000142728.91330.94","article-title":"Posttransplantation delirium: a review","volume":"9","author":"Dyrud","year":"2004","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0860","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.healun.2013.01.1046","article-title":"Nature and correlates of post-traumatic stress symptomatology in lung transplant recipients","volume":"32","author":"Gries","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0861","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.hlc.2016.12.010","article-title":"Neurocognitive and psychiatric issues post cardiac surgery","volume":"26","author":"Indja","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.healun.2022.10.015_bib0862","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/TP.0000000000000901","article-title":"Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis","volume":"100","author":"Dew","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0863","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archsurg.137.3.316","article-title":"St John's wort supplements endanger the success of organ transplantation","volume":"137","author":"Ernst","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0864","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2006.03.019","article-title":"Anti-depressive therapies after heart transplantation","volume":"25","author":"Fusar-Poli","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0865","first-page":"96","article-title":"The heart as a transplanted organ: unspoken struggles of personal identity among adolescent recipients","volume":"35","author":"Anthony","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0866","doi-asserted-by":"crossref","first-page":"e13335","DOI":"10.1111\/ctr.13335","article-title":"A comparison of quality of life and psychological distress in heart transplantation patients at adult and pediatric ages","volume":"33","author":"Cavalli","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0867","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1474515113519519","article-title":"The effectiveness of non-pharmacological interventions in improving psychological outcomes for heart transplant recipients: a systematic review","volume":"13","author":"Conway","year":"2014","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.healun.2022.10.015_bib0868","doi-asserted-by":"crossref","first-page":"e13110","DOI":"10.1111\/petr.13110","article-title":"Psychosocial functioning in pediatric heart transplant recipients and their families","volume":"22","author":"Cousino","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0869","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2019.10.022","article-title":"Disorders of adjustment, mood, and anxiety in children and adolescents undergoing heart transplantation and the association of ventricular assist device support","volume":"217","author":"Diaz","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.healun.2022.10.015_bib0870","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/archdischild-2018-315682","article-title":"Paediatric heart transplantation: an update","volume":"104","author":"Reinhardt","year":"2019","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.healun.2022.10.015_bib0871","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13380","article-title":"Psychotropic medication use trends in a large pediatric and young adult solid organ transplant population","volume":"23","author":"Samsel","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0872","doi-asserted-by":"crossref","first-page":"18","DOI":"10.24869\/psyd.2019.18","article-title":"Transplantation psychiatry: an overview","volume":"31","author":"Medved","year":"2019","journal-title":"Psychiatria Danubina"},{"key":"10.1016\/j.healun.2022.10.015_bib0873","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","article-title":"Cardiac allograft vasculopathy after heart transplantation: risk factors and management","volume":"23","author":"Valantine","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0874","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4254\/wjh.v9.i22.953","article-title":"Addictive behaviors in liver transplant recipients: the real problem?","volume":"9","author":"Donnadieu-Rigole","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.healun.2022.10.015_bib0875","series-title":"Psychosocial care of end-stage organ disease and transplant patients","first-page":"493","article-title":"Substance use disorders in transplant patients","author":"Fireman","year":"2019"},{"key":"10.1016\/j.healun.2022.10.015_bib0876","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1600-6143.2007.02119.x","article-title":"Smoking after cardiac transplantation","volume":"8","author":"Botha","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0877","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.21037\/jtd.2018.07.16","article-title":"Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management","volume":"10","author":"Hofmann","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0878","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12890-019-0950-3","article-title":"The association between e-cigarette use and asthma among never combustible cigarette smokers: behavioral risk factor surveillance system (BRFSS) 2016 & 2017","volume":"19","author":"Osei","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0879","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.amepre.2019.10.014","article-title":"Association between E-cigarette use and chronic obstructive pulmonary disease by smoking status: behavioral risk factor surveillance system 2016 and 2017","volume":"58","author":"Osei","year":"2020","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0880","doi-asserted-by":"crossref","first-page":"949-954 e2","DOI":"10.1016\/j.amjmed.2019.02.016","article-title":"Association between E-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers","volume":"132","author":"Osei","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0881","series-title":"Cochrane database of systematic reviews","article-title":"Electronic cigarettes for smoking cessation and reduction","author":"McRobbie","year":"2014"},{"key":"10.1016\/j.healun.2022.10.015_bib0882","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/TP.0000000000002599","article-title":"Cannabis dependence or abuse in kidney transplantation: implications for posttransplant outcomes","volume":"103","author":"Alhamad","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0883","doi-asserted-by":"crossref","first-page":"e13456","DOI":"10.1111\/ctr.13456","article-title":"Marijuana use in transplantation: a call for clarity","volume":"33","author":"Levi","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0884","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/TP.0b013e31829f7579","article-title":"Alcohol and substance abuse in solid-organ transplant recipients","volume":"96","author":"Parker","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0885","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/TP.0b013e3181ce77e5","article-title":"Return to work and social participation: does type of organ transplantation matter?","volume":"89","author":"De Baere","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0886","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/TP.0b013e31819ca1ee","article-title":"Return to work after heart transplantation: discrepancy with subjective work ability","volume":"87","author":"Kristen","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.10.015_bib0887","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/HCR.0000000000000365","article-title":"A cross-sectional study of return to work rate following heart transplantation and the contributing role of illness perceptions","volume":"39","author":"Thomson","year":"2019","journal-title":"J Cardiopulm Rehabil Prevent"},{"key":"10.1016\/j.healun.2022.10.015_bib0888","doi-asserted-by":"crossref","first-page":"E599","DOI":"10.1111\/j.1399-0012.2011.01507.x","article-title":"Factors associated with work status at 5 and 10 years after heart transplantation: factors associated with work status after HT","volume":"25","author":"White-Williams","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0889","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/1471-2458-11-615","article-title":"Occupational therapy and return to work: a systematic literature review","volume":"11","author":"D\u00e9siron","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.healun.2022.10.015_bib0890","first-page":"e13462","article-title":"Recipient working status is independently associated with outcomes in heart and lung transplantation","author":"Rudasill","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0891","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/chd.12513","article-title":"Employment after heart transplantation among adults with congenital heart disease","volume":"12","author":"Tumin","year":"2017","journal-title":"Congenital Heart Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0892","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10926-018-9804-8","article-title":"Predictors of return to work 12 months after solid organ transplantation: results from the swiss transplant cohort study","volume":"29","author":"Vieux","year":"2019","journal-title":"J Occup Rehabil"},{"key":"10.1016\/j.healun.2022.10.015_bib0893","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/157340311797484277","article-title":"Psychosocial implications during adolescence for infant heart transplant recipients","volume":"7","author":"Krishnamurthy","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.healun.2022.10.015_bib0894","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.healun.2008.07.012","article-title":"Developmental outcomes after pediatric heart transplantation","volume":"27","author":"Chinnock","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0895","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cardfail.2014.07.001","article-title":"Cognitive and psycholologic considerations in pediatric heart failure","volume":"20","author":"Hollander","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0896","unstructured":"Assessing fitness to drive for commercial and private vehicle drivers: medical standards for licensing and clinical management guidelines. Available at:https:\/\/austroadscomau\/__data\/assets\/pdf_file\/0022\/104197\/AP-G56-17_Assessing_fitness_to_drive_2016_amended_Aug2017pdf. 2017."},{"key":"10.1016\/j.healun.2022.10.015_bib0897","series-title":"Influence of chronic illness on crash involvement of motor vehicle drivers","first-page":"209","author":"Charlton","year":"2010"},{"key":"10.1016\/j.healun.2022.10.015_bib0898","first-page":"59","article-title":"New standards for driving and cardiovascular diseases","volume":"1","author":"Vijgen","year":"2013","journal-title":"Eur. Work. Gr. Driv. Cardiovasc. Dis"},{"key":"10.1016\/j.healun.2022.10.015_bib0899","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/s1010-7940(02)00807-2","article-title":"Neurocognitive impairment and driving performance after coronary artery bypass surgery","volume":"23","author":"Ahlgren","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.10.015_bib0900","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.rec.2018.06.015","article-title":"Heart disease and vehicle driving: novelties in European and Spanish law","volume":"71","author":"Garc\u00eda Lled\u00f3","year":"2018","journal-title":"Rev Espa\u00f1ola Cardiol (English Edition)"},{"key":"10.1016\/j.healun.2022.10.015_bib0901","first-page":"692","article-title":"Fitness to drive in cardiovascular disease","volume":"114","author":"Klein","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.healun.2022.10.015_bib0902","first-page":"176","article-title":"[Car driving after cardiac surgery: clinical aspects, regulations, and legal implications]","volume":"8","author":"Casadei","year":"2007","journal-title":"G Ital Cardiol (Rome)"},{"key":"10.1016\/j.healun.2022.10.015_bib0903","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2337\/dc08-1510","article-title":"Driving mishaps among individuals with type 1 diabetes: a prospective study","volume":"32","author":"Cox","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.healun.2022.10.015_bib0904","first-page":"797","article-title":"Ventricular fibrillation during acute rejection after heart transplantation","volume":"11","author":"de Jonge","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0905","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.hrthm.2014.07.016","article-title":"Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation","volume":"11","author":"Vakil","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.healun.2022.10.015_bib0906","series-title":"Assessing fitness to drive: a guide for medical professionals","author":"UK","year":"2021"},{"key":"10.1016\/j.healun.2022.10.015_bib0907","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0002-9149(94)90587-8","article-title":"Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy","volume":"74","author":"Bortman","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0908","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2019.12.066","article-title":"Sarcoidosis diagnosed on granulomas in the explanted heart after transplantation: results of a French nationwide study","volume":"307","author":"Chazal","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0909","first-page":"e48","article-title":"Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy","volume":"25","author":"Luk","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0910","first-page":"904","article-title":"Verification of heart disease","volume":"5","author":"Raeisi-Giglou","year":"2017","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0911","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107190","article-title":"Clinicopathological manifestations of myocarditis in a heart failure population","volume":"45","author":"Buja","year":"2020","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.healun.2022.10.015_bib0912","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2019.05.020","article-title":"Comparison of clinical and morphologic findings in patients with cardiac sarcoidosis severe enough to warrant heart transplantation in those with -vs- those without non-caseating granulomas in the explanted heart (Burnt-Out Sarcoid)","volume":"124","author":"Fathima","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0913","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","article-title":"Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy: a clinical-pathological study of 30 explanted hearts","volume":"9","author":"Galati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.10.015_bib0914","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000496163","article-title":"Marked vascular dysfunction in a case of peripartum cardiomyopathy","volume":"56","author":"Khanamiri","year":"2019","journal-title":"J Vasc Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0915","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.02.049","article-title":"Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure","volume":"73","author":"Nagaraju","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0916","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.carpath.2015.06.002","article-title":"Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation","volume":"24","author":"Ottaviani","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.healun.2022.10.015_bib0917","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2016.03.004","article-title":"Left ventricular noncompaction cardiomyopathy in end-stage heart failure patients undergoing orthotopic heart transplantation","volume":"25","author":"Ottaviani","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.healun.2022.10.015_bib0918","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/eci.12549","article-title":"Determinants of ventricular arrhythmias in human explanted hearts with dilated cardiomyopathy","volume":"45","author":"Parajuli","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.healun.2022.10.015_bib0919","first-page":"158","article-title":"The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts","volume":"5","author":"Wolfsohn","year":"1992","journal-title":"Mod Pathol"},{"key":"10.1016\/j.healun.2022.10.015_bib0920","article-title":"Response by Divakaran et al to Letter Regarding Article, \u201cDiagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: an imaging-histologic correlation study in patients undergoing cardiac transplantation","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.10.015_bib0921","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.healun.2009.06.019","article-title":"Routine performance of endomyocardial biopsy decreases the incidence of orthotopic heart transplant for myocarditis","volume":"28","author":"Hill","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0922","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/13506129.2012.684810","article-title":"New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis","volume":"19","author":"Leone","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.healun.2022.10.015_bib0923","doi-asserted-by":"crossref","unstructured":"Lin LQ, Kazmirczak F, Chen K-HA, et al. Impact of cardiovascular magnetic resonance imaging on identifying the etiology of cardiomyopathy in patients undergoing cardiac transplantation. Sci Rep 2018;8:16212.","DOI":"10.1038\/s41598-018-34648-5"},{"key":"10.1016\/j.healun.2022.10.015_bib0924","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trsl.2016.02.006","article-title":"Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure","volume":"172","author":"Sakamuri","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.healun.2022.10.015_bib0925","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1399-3046.2007.00804.x","article-title":"Histology of the explanted hearts of children transplanted for dilated cardiomyopathy","volume":"12","author":"Crossland","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0926","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00246-015-1327-x","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia (ARVC\/D): review of 16 pediatric cases and a proposal of modified pediatric criteria","volume":"37","author":"Deshpande","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0927","doi-asserted-by":"crossref","first-page":"E679","DOI":"10.1111\/ctr.12250","article-title":"Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation","volume":"27","author":"Kobashigawa","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0928","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1399-3046.2008.01087.x","article-title":"Clinico-pathologic findings in end-stage pediatric heart transplant grafts","volume":"13","author":"Perens","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0929","doi-asserted-by":"crossref","unstructured":"Leone O, Angelini A, Bruneval P, Potena L. The pathology of cardiac transplantation: a clinical and pathological perspective. 2016:1 online resource (448 pages) illustrations.","DOI":"10.1007\/978-3-319-46386-5"},{"key":"10.1016\/j.healun.2022.10.015_bib0930","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","article-title":"Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association","volume":"133","author":"Stout","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.015_bib0931","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0000000000000589","article-title":"Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications","volume":"19","author":"Girolami","year":"2018","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0932","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0933","first-page":"184","article-title":"Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening","volume":"69","author":"Smith","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.healun.2022.10.015_bib0934","doi-asserted-by":"crossref","first-page":"101687","DOI":"10.1016\/j.bpg.2020.101687","article-title":"Non-adherence and transition clinics","volume":"46-47","author":"Kelly","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.healun.2022.10.015_bib0935","doi-asserted-by":"crossref","unstructured":"Anton CM, Anton K, Butts RJ. Preparing for transition: the effects of a structured transition program on adolescent heart transplant patients\u2019 adherence and transplant knowledge. Pediatr Transplant 2019;231-9.","DOI":"10.1111\/petr.13544"},{"key":"10.1016\/j.healun.2022.10.015_bib0936","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00246-017-1763-x","article-title":"Pediatric heart transplantation: transitioning to adult care (TRANSIT): baseline findings","volume":"39","author":"Grady","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0937","doi-asserted-by":"crossref","first-page":"A546","DOI":"10.1016\/S0735-1097(15)60546-0","article-title":"Provision of transition education and referral patterns from pediatric cardiology to adult cardiac care","volume":"65","author":"Harbison","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.015_bib0938","unstructured":"Pediatrics ACoCACoPAAo. Congenital heart disease transition tools 2016."},{"key":"10.1016\/j.healun.2022.10.015_bib0939","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/archdischild-2014-307423","article-title":"Implementing transition: ready steady go","volume":"100","author":"Nagra","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.healun.2022.10.015_bib0940","unstructured":"Transition from children's to adults\u2019 services for young people using health or social care services: NICE Guideline (NG43). Available at: https:\/\/wwwniceorguk\/guidance\/ng43. 2016."},{"key":"10.1016\/j.healun.2022.10.015_bib0941","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7182\/pit2014911","article-title":"Transition to self-management after pediatric heart transplant","volume":"24","author":"Meaux","year":"2014","journal-title":"Prog Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0942","doi-asserted-by":"crossref","unstructured":"Buchan CA, Kotton CN. Practice tAIDCo, Travel medicine, transplant tourism, and the solid organ transplant recipient\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:1-16.","DOI":"10.1111\/ctr.13529"},{"key":"10.1016\/j.healun.2022.10.015_bib0943","series-title":"Centers for Disease Control and Prevention. CDC Yellow Book 2020: Health Information for International Travel","article-title":"Travelers with Additional Considerations-Chapter 5","author":"Kotton","year":"2017"},{"key":"10.1016\/j.healun.2022.10.015_bib0944","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1034\/j.1399-0012.2002.01144.x","article-title":"Traveling after heart transplantation: traveling after heart transplantation","volume":"16","author":"Kofidis","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0945","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.idh.2018.09.083","article-title":"Pre-travel counseling for immunocompromised travelers: a 12-year single-center retrospective review","volume":"24","author":"Tan","year":"2019","journal-title":"Infect Dis Health"},{"key":"10.1016\/j.healun.2022.10.015_bib0946","doi-asserted-by":"crossref","first-page":"taw058","DOI":"10.1093\/jtm\/taw058","article-title":"Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients","volume":"23","author":"Trubiano","year":"2016","journal-title":"J Travel Med"},{"key":"10.1016\/j.healun.2022.10.015_bib0947","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.healun.2009.10.001","article-title":"The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation","volume":"28","author":"Danziger-Isakov","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0948","unstructured":"Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic. Available at:https:\/\/ishltorg\/ishlt\/media\/documents\/SARS-CoV-2_-Guidance-for-Cardiothoracic-Transplant-and-VAD-centerspdf. 2020."},{"key":"10.1016\/j.healun.2022.10.015_bib0949","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.healun.2020.04.019","article-title":"Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 task force statement","volume":"39","author":"Holm","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0950","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/ajt.15933","article-title":"Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: a By-proxy Society Recommendation Consensus approach","volume":"20","author":"Ritschl","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0951","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/ajt.15832","article-title":"Coronavirus disease 2019: implications of emerging infections for transplantation","volume":"20","author":"Michaels","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0952","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.14086","article-title":"Evolving impact of COVID-19 on transplant center practices and policies in the United States","volume":"34","author":"Boyarsky","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0953","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2022.10.015_bib0954","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1034\/j.1600-6143.2003.00197.x","article-title":"Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening: SARS in transplant","volume":"3","author":"Kumar","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.10.015_bib0955","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:49:31Z","timestamp":1760950171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822021854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":955,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1053249822021854"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.10.015","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}